Category: Science

  • MIL-OSI Australia: State Memorial for David Polson AM

    Source: New South Wales Government 2

    Headline: State Memorial for David Polson AM

    Published: 13 February 2025

    Released by: The Premier


    The NSW Government is today announcing that the family of David Polson AM has the accepted the offer of a State Memorial Service.

    Mr Polson, who passed away on 10 February 2025, made significant contributions to the LGBTQIA+ community over his lifetime.

    His family accepted the NSW Government’s offer of a State Memorial, following his death at Sydney’s St Vincent’s Hospital on Monday, aged 70.

    The State Memorial will be held on the morning of Wednesday, 12 March.

    As one of the first 400 men diagnosed with HIV/AIDS in Australia in the 1980s at the age of 29, Mr Polson was a long-term survivor, with his commitment to advocacy supported by the 28 HIV drug trials he volunteered for over almost four decades.

    In 2021, he was recognised as a Community Champion by the National Association of People Living with HIV, Gilead Sciences and Positive Life NSW for his services to HIV education and awareness.

    In 2023, he was awarded Member of the Order of Australia for ‘significant service to community health through HIV education and advocacy’.

    He was the Emeritus Founding Chair of Qtopia Sydney, Sydney’s first Queer Museum that opened in Darlinghurst in 2024.

    More details on the March 12 State Memorial will be available in the coming weeks at NSW Government State Services.

    Premier of New South Wales, Chris Minns said:

    “David Polson was a ‘trailblazer’ for bravely continually challenging the HIV stigma.

    “His experience and advocacy contributed to life saving medications and significant advancements with a far-reaching international impact for those living with HIV.

    “I have been honoured to work with David over a number of years as he continued to advocate for the LGBTQIA+ community including later in his life and know that his legacy will live on in the community for generations.”

    Leader of the Government in the Legislative Council, Penny Sharpe said:

    “There are people alive today because of the courage and bravery of David Polson.

    “It is a fitting tribute that he has a state memorial to acknowledge his work and share the story of LGBTQIA+ activism in NSW and David’s role in it.

    “David Polson was a genuine hero of the community whose life profoundly helped others.”

    MIL OSI News

  • MIL-OSI New Zealand: Growing the economy means shrinking the Government

    Source: ACT Party

    “The Government’s Going for Growth agenda shows New Zealand has turned the corner. Governments ignored economic growth, taking wealth for granted and wasting billions until we started feeling poor,” says ACT Leader David Seymour.

    “This Government’s focus on growth is team effort. ACT’s impact can be seen in a number of priority areas.

    “To develop talent, we’ve implemented the attendance action plan, opened the first charter schools, and changed the Accredited Employer Work Visa. We’re removing red tape in Early Childhood Education and continuing reforms to get job seekers into work.

    “For competitive business settings, we’ve repealed so-called ‘Fair Pay Agreements’, extended 90-Day Trials to all businesses, and revoked difficult requirements for accessing credit. We’re leading an inquiry into rural banking practices, reforming health and safety laws, reforming the Holidays Act and Employment Relations Act, conducting sector reviews for regulation of Agricultural and Horticultural Products, and Hairdressing and Barbering, improving Government Procurement Rules, and progressing the Regulatory Standards Bill.

    “To promote global trade and investment, we’re reforming the Overseas Investment Act and have launched a new Minerals Strategy and Critical Minerals List.

    “For innovation, technology and science, we’re liberalising genetic engineering laws.

    “To deliver infrastructure for growth, we’re reforming and replacing the Resource Management Act and have established National Infrastructure Funding and Financing Limited. We’re developing the 30-year National Infrastructure Plan, and finalising the first Regional Deal between central and local government.

    The big challenge

    “The big challenge for growth is shrinking the Government part of the economy. There are only two halves to any economy, the public and the private sector, and it’s the private sector that provides the growth.

    “Every dollar taxed to fund the public sector is a dollar a consumer can’t spend, or a business can’t reinvest in new jobs. Business is about taking risk, every percentage point taken in tax makes it less rewarding when the risks work out. Rational people invest less when taxes are higher.

    “In that sense, the Government still has a big hill to climb, and it’s the mountain of waste left by the last Government. Pre-COVID, government spending amounted to 28 per cent of the economy, now it is 34. The Government must be relentless in reducing its spending.

    “It is not only taxing and spending that holds people back, but regulating. Every compliance fee, every delay waiting for Government permission is a cost put on business. Like taxes, regulations drain the energy from business.

    “That’s why it’s essential that the Government cuts red tape at every opportunity. We must run the ruler over rules that don’t make sense, then delete them. The commitment to passing the Regulatory Standards Bill is a landmark shift in the battle against red tape in favour of wealth and innovation.

    “I’m proud of ACT’s contributions to this Government, especially the many contributions in this plan. For the first time in decades, we have a Government where it’s understood that Government activity and private activity compete for time and money. To grow the economy, we must shrink the Government.”

    MIL OSI New Zealand News

  • MIL-OSI USA: Markey, Warren Slam Trump Administration for Causing “Chaos and Upheaval” at Massachusetts Research Institutions, Demand Answers from NIH and NSF

    US Senate News:

    Source: United States Senator for Massachusetts Ed Markey

    “Trump Administration actions are endangering life-saving research and economic growth in Massachusetts and across the country.”

    “The chaos caused by the Trump administration is unacceptable—and you owe researchers and patients in Massachusetts and beyond an explanation about what is going on at your agencies.” 

    Text of Letter (PDF) 

    Washington (February 12, 2025) – Senators Edward J. Markey (D-Mass.), and Elizabeth Warren (D-Mass.) today wrote to the National Institutes of Health (NIH) and the National Science Foundation (NSF) with concerns about the ongoing Trump Administration funding cuts at Massachusetts research institutions. 

    The NIH and NSF are the largest public funders of research in the United States — fueling the development of lifesaving treatments for diseases like cancer, heart disease, and diabetes, tools for the early detection of Alzheimer’s disease, and more. This funding is particularly indispensable in Massachusetts, where dozens of world-renowned universities, hospitals, and research institutions rely on NIH and NSF grants to support cutting-edge research that benefits the U.S. economy and patients around the world.

    Within days of taking office, the Trump Administration called for an immediate pause on all public communications from HHS, NIH’s parent organization, and one week later, paused all activities related to the disbursement of funds. This pause was blocked by a federal judge, but the Trump administration has refused to fully comply with the order to unfreeze funds. 

    On February 7, the NIH announced that all new and existing research awards would face major cuts, due to reduction in the “indirect cost rate.” Following a legal challenge by 22 state attorneys general, led by Massachusetts Attorney General Campbell, a federal judge issued a temporary order blocking the cut within those states. Still, researchers, students, and institutions are facing huge budget cuts and continued uncertainty.

    These “Trump Administration actions are endangering life-saving research and economic growth in Massachusetts and across the country,” wrote the lawmakers. 

    “The chaos caused by the Trump administration is unacceptable—and you owe researchers and patients in Massachusetts and beyond an explanation about what is going on at your agencies,” continued the lawmakers.

    The Senators’ offices conducted interviews with institutions who are among the top recipients of NIH and NSF funding in Massachusetts about the impact these cuts would have on researchers’ projects, careers, and on the local economy. These interviews revealed that: 

    1. The funding freezes and cuts at NIH and NSF have caused chaos and confusion at Massachusetts research institutions. Representatives at Massachusetts research institutions described a “hunger for clear guidance on what is impacted and what isn’t” as investigators scramble to save their work and plan for the years and months ahead. They are concerned about existing grants being clawed back, afraid to ask for clarification for fear they’ll have a “target on their back,” and in some instances even unable to “buy a book or a pencil.” 
    2. The funding cut offs are impeding research carried out by Massachusetts institutions that enable critical, lifesaving care. NIH and NSF funding saves Americans’ lives by sponsoring life-saving clinical trials, many of which are conducted at Massachusetts institutions. Thus, for some, the consequences of the funding pauses could be life or death: “if you’re a cancer patient in a clinical trial, it is not a theoretical undertaking, it is treatment.” 
    3. Federal funding disruptions at Massachusetts institutions puts the future of a highly skilled STEM workforce at risk.Nearly half of all science and engineering doctoral recipients graduating from U.S. research institutions have received federal research funding during their graduate studies. According to conversations with Massachusetts research institution representatives, “higher education is a big industry in Massachusetts, we’re training the workforce at every level;” pulling back this funding risks “a situation where you can only earn a PhD if you’re already wealthy.” 
    4. Freezes and cuts in federal research funding at Massachusetts institutions will be a critical hit to the innovation that has cemented the United States as a vanguard in healthcare.Massachusetts scientists are using NIH grants to create new cancer drugs; develop new technologies—like the bionic pancreas—to treat disease; study ways to combat the opioid epidemic; and identify risk factors for heart disease, among other critical endeavors. As representatives from Massachusetts-based research institutions said, “if anyone in the world has a serious disease and they want to come to the US – they want to come to Boston.” 
    5. Federal funding disruptions will harm the Massachusetts and United States economies.The NIH is the largest single public funder of biomedical and behavioral research in the world, and in fiscal year 2023 NIH funding generated over $90 billion in economic activity in the United States. In Massachusetts along that same year, the NIH awarded $3.5 billion in grants in contracts that directly supported 28,842 jobs and nearly $7.5 billion in economic activity. 

    “The unprecedented actions taken by the Trump Administration will undermine the United States’ research edge—whether through abandoned research projects, staffing shortages, or a “brain drain” in our biotech workforce as young, budding scientists opt for other careers and countries with greater certainty,” concluded the lawmakers

    The Senators urged the agencies to end the funding freeze and threats to cut grant expenditures and provide clarity on their directive-issuing processes and the rationale behind the indirect cost cap reduction by February 26, 2025. In 2017, following President Trump’s budget proposal seeking massive cuts to the NIH, Senator Warren released a report detailing the importance of NIH funding to Massachusetts. 

    MIL OSI USA News

  • MIL-OSI USA: Cantwell Votes NO On Advancing RFK Jr. for HHS Secretary: “The Kind Of Research We’re Talking About Here Is The Kind That Saves Lives”

    US Senate News:

    Source: United States Senator for Washington Maria Cantwell

    02.12.25

    Cantwell Votes NO On Advancing RFK Jr. for HHS Secretary: “The Kind Of Research We’re Talking About Here Is The Kind That Saves Lives”

    In Senate floor speech, says RFK Jr.’s anti-science views put U.S. medical innovation leadership at risk; would hinder response to health crises like avian flu; Trump Administration plans to slash NIH funding put lifesaving research – and 12k jobs – in WA state at risk

    WASHINGTON, D.C. – Today, U.S. Senator Maria Cantwell (D-WA), a senior member of the Senate Finance Committee and ranking member of the Senate Committee on Commerce, Science, and Transportation, voted against closing debate on Robert F. Kennedy Jr. – President Trump’s nominee to serve as Secretary of Health and Human Services – and advancing toward his final confirmation vote.

    In a speech delivered on the Senate floor, Sen. Cantwell urged her colleagues to follow suit, cautioning that “President Trump’s nominee would get us stuck in conspiracy theories that would cost us lives.”

    “Now we are at the possibility of the beginning of another crisis, the avian flu. This crisis is yet another reminder of the importance of medical research and collaboration,” Sen. Cantwell said. “Does it make sense to cut science at the time we might have another pandemic? Does it make sense to continue to cut the collaborative efforts of research?”

    “My state is a global leader in medical innovation. From research, to biotech, to getting drugs to the market — in 2023 the National Institutes of Health awarded $1.2 billion in highly competitive grants to 65 different organizations in the State of Washington. This supported about 12,000 jobs and generated close to $3 billion in economic activity. So yes, we know a little something about global health and innovation,” Sen. Cantwell continued. “The kind of research we’re talking about here is the kind that saves lives. And this, ultimately, is about making an investment in saving the lives of people.”

    The Senate ultimately voted to invoke cloture on RFK Jr.’s nomination, 53-47. His final confirmation vote is currently scheduled for tomorrow morning.

    Last week, Sen. Cantwell voted no on advancing RFK Jr.’s nomination out of the Senate Finance Committee, citing his waffling on the safety of vaccines. Her no vote followed a committee hearing in January, when Sen. Cantwell grilled him on his anti-science and anti-vaccine views, and his promise to cut 600 employees from the National Institutes of Health.

    For decades, Sen. Cantwell has remained a staunch supporter of medical innovation and evidence-based science, including treatments for fentanyl addiction, abortion, vaccinations, stem cell research, and more.

    Video of Sen. Cantwell’s speech on the Senate floor today is available HERE, audio HERE, and transcript HERE.



    MIL OSI USA News

  • MIL-OSI New Zealand: Auckland Council’s intern adventures in Healthy Waters end

    Source: Auckland Council

    In December last year, 50 ambitious, wide-eyed twenty-somethings strode into Auckland Council, each wearing an outfit meticulously chosen to scream “hire me!” (or at least whisper it convincingly). Day one was a heady mix of excitement, nerves, and an almost audible chorus of imposter syndrome echoing off the walls. As we exchanged awkward smiles and first-day introductions, one question loomed large: why us? 

    For three of our interns, the answer lies in their unique stories and unstoppable passion. 

    Georgia Dennis: a life of green perspectives 

    Georgia Dennis is the person you’d want to sit next to on a plane — and not just because she’s clocked enough frequent flyer miles to rival a seasoned pilot. From backpacking across South America to attending high school in Italy, Georgia’s experiences have shaped her passion for sustainability. 

    A small Guatemalan town devoid of plastic opened her eyes to a world without mass production. A month-long conversation with a Venezuelan man in Ecuador taught her how privilege shapes opportunity. Canada showed her how New Zealand leads the way in environmental action. Her most important lesson? Perspective. 

    Now, pursuing a master’s in environmental management and armed with degrees in physics and philosophy, Georgia is bringing that perspective and purpose to her role. 

    “Working at Council feels like a way to repay the environment for all we’ve taken from it,” she says. Georgia believes the world isn’t black and white, but if we all embraced a little more “green”, it might just thrive. 

    Deshma Weerapperuma: passionate about rocks and ripple effects 

    “I love rocks,” Deshma declared at three, setting the stage for a lifelong passion that’s now guiding her through a degree in Earth Sciences.  

    Born in Botswana and raised in New Zealand, Deshma’s love for nature is as vast as her hobbies. She climbs mountains despite being terrified of heights, bakes stunning treats through her own pâtisserie business, and plays competitive tennis when she’s not sampling water as a Safeswim intern. 

    Driving to Auckland’s beaches and waterways for Safeswim makes her work feel like an adventure, blending her passion for the outdoors with meaningful environmental action. Whether she’s scaling rocks or analysing them, Deshma’s enthusiasm reminds us all to chase what we love — even if it’s scary sometimes. 

    Olivia Wentzell: where wildlife meets waterways 

    If animals, photography, and travel had a mascot, it would be Olivia Wentzell. Splitting her early years between Montana and Nelson, Olivia developed a “dream big” mindset. Now pursuing a degree in zoology, Olivia balances volunteering at Auckland Zoo and a wild bird hospital with her role on the Overland Flow Path Compliance Team. 

    Through site visits and stormwater projects, she’s learning how protecting waterways supports biodiversity and marine life. She sees her internship as more than a stepping stone — it’s a chance to make lasting connections while safeguarding New Zealand’s future ecosystems. 

    The answer to “why us?” 

    So, why us? Because we care. And that’s what makes all the difference. 

    It’s not about the miles we’ve travelled, the hobbies we’ve mastered, or the degrees we’re earning. It’s about our shared drive to make a difference. Every one of us, from bakers to backpackers, climbers to conservationists, brings passion to Auckland Council. 

    So, after 11 weeks packed with hard-work, meetings, and lots of laughter, the 2025 Intern Programme has come to a close.   

    Clarke Mckinney, Auckland Councils Healthy Waters Recourse Management Team Manager, and the interns work dad, thinks this group of interns has the potential to go far.  

    “The interns have exceeded all expectations: their curiosity, passion and skill have brought immense value to the council, and we look forward to repeating the success of this programme next year!” 

    More information on Auckland Council’s graduate programme is available via the Auckland Council Careers website.

    Written by Auckland Council intern Kaavya Ghoshal of Healthy Waters. 

    MIL OSI New Zealand News

  • MIL-Evening Report: Indigenous knowledge merges with science to protect people from fish poisoning in Vanuatu

    Source: The Conversation (Au and NZ) – By Meg Parsons, Associate Professor in Historical Geography, University of Auckland, Waipapa Taumata Rau

    Wikimedia/Louisa Cass/AusAID, CC BY-SA

    Ciguatera fish poisoning is the world’s most frequently reported seafood-borne illness.

    It poses a serious health risk to tropical coastal communities, with some of the highest rates reported in Vanuatu. But now, Indigenous knowledge provides crucial insights for predicting fish poisoning outbreaks.

    Our study documents a collaboration between scientists and Indigenous knowledge holders on Vanuatu’s Ambae island. It offers a powerful new model designed to protect people’s health in vulnerable regions.

    Ecological indicators and fish poisoning risk

    Ciguatera poisoning occurs when people eat fish contaminated with ciguatoxins produced by marine algae that accumulate in reef-feeding fish. Symptoms can range from nausea and muscle pain to severe neurological effects. In some cases, the poisoning can lead to serious illness or even death.

    For millennia, Ambae islanders have relied on their knowledge of the local environment to manage their lands and seas in a sustainable manner. They have observed ecological indicators, including environmental changes that precede ciguatera fish poisoning events, to monitor and respond to risks.

    For instance, they note how heavy rains wash volcanic sediments into the ocean, triggering algal blooms that produce ciguatoxins. Likewise, jellyfish blooms and shifts in coral growth signal imbalances in the marine ecosystem, often preceding toxic fish contamination.

    These ecological indicators, passed down through oral traditions, have guided community decisions about fishing practices and food consumption.

    The islanders’ traditional observations are now being woven together with scientific data to create an early-warning system known as the Gigila Framework, named after a local term meaning “risk onset”, to aid public health responses.

    Our research documents 14 key environmental indicators used by Ambae island communities. We cross-referenced these indicators with climate, geological and marine data to confirm their accuracy. By comparing Ambae islanders’ observations with scientific data, we identify which Indigenous indicators can be used to assess when and where ciguatera fish poisoning outbreaks take place.

    Ambae islanders use ecological observations guide decisions about fishing practices and food consumption.
    Allan Rarai, CC BY-SA

    Lessons for other regions

    The Gigila framework is a community-driven early-warning system designed to reduce the risk of people eating contaminated fish. It uses visual markers, such as dials, to indicate risk levels.

    Village elders appoint local people to act as observers to track environmental changes. They then share their observations (such as jellyfish blooms) with government agencies.

    The Gigila model helps local community members make informed decisions about if and where they go fishing. It also strengthens collaborations between Indigenous knowledge holders, scientists and medical professionals.

    The approach makes health risk information more accessible and practical. Instead of replacing Indigenous knowledge, it seeks to empower and enhance it. It also helps to ensure that younger generations learn about it.

    Challenges of working with different knowledge systems

    The weaving together of Indigenous knowledge with scientific knowledge is not without hurdles.

    Indigenous knowledge practices are deeply rooted in local culture, passed on through oral traditions and combined with lived experiences. Scientific research, in contrast, relies on standardised testing, numerical data and universal theories.

    Unsurprisingly, miscommunication between scientists and Indigenous knowledge holders abounds. Scientists sometimes misinterpret and misunderstand Indigenous knowledge and treat it like data to be extracted and exploited. In doing so, Indigenous peoples’ sacred knowledge systems, cultural identities and ways of life are disrespected and marginalised.

    However, the success of the Gigila framework shows that respectful collaborations between scientists and Indigenous knowledge holders are possible. At the heart of this collaboration is respect for Indigenous knowledge holders’ expertise.

    Another vital component is that Indigenous communities are active participants in helping to create and maintain the early-warning system designed to protect their health. This approach highlights the strengths of combining different knowledge systems to address local environmental issues, which can be adapted to fit different problems and risks.

    Local and global applications

    The Gigila framework holds potential beyond Vanuatu. Many small island nations face similar challenges from fish poisoning. Climate change is making these risks worse by creating the environmental conditions that toxic algae favour.

    Warmer sea temperatures, ocean acidification, more intense and frequent extreme weather events and changes in the distribution of fish species are all contributing to more frequent fish poisoning outbreaks worldwide, including in areas with no history of it.

    This highlights the need for enhanced monitoring and management strategies to reduce the impacts on human health and communities that depend on fisheries.

    Other communities could develop their own early-warning systems drawing on the Gigila framework. Globally, Indigenous peoples manage vast ecosystems. Their knowledge and environmental guardianship practices are critical for sustainability and environmental health, but are often sidelined in science and policy.

    The Gigila framework highlights the continued relevance and importance of Indigenous knowledge and the need for Indigenous knowledge holders and scientists to work together in a respectful and equitable manner.

    As climate change accelerates, partnerships between communities and researchers will be crucial. Governments should support locally led initiatives that promote the deployment of Indigenous knowledge with scientific expertise to produce solutions that are both effective and culturally grounded.

    The Gigila framework offers a compelling example of what’s possible when different ways of knowing are woven together. By embracing these approaches, we can build stronger, more resilient and adaptable communities in the face of an uncertain future.

    Allan Rarai receives funding from the Association of the Commonwealth Universities through the Ocean Country Partnership Programme research grant.

    Meg Parsons does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    ref. Indigenous knowledge merges with science to protect people from fish poisoning in Vanuatu – https://theconversation.com/indigenous-knowledge-merges-with-science-to-protect-people-from-fish-poisoning-in-vanuatu-249469

    MIL OSI AnalysisEveningReport.nz

  • MIL-Evening Report: Antarctic research has long been hamstrung by reliance on one icebreaker and sporadic funding. That might be about to change

    Source: The Conversation (Au and NZ) – By Jane Younger, Lecturer in Southern Ocean Vertebrate Ecology, Institute for Marine and Antarctic Studies, University of Tasmania

    Australia’s Antarctic territory represents the largest sliver of the ice continent. For decades, Australian scientists have headed to one of our three bases – Mawson, Davis and Casey – as well as the base on sub-Antarctic Macquarie Island, to research everything from ecology to climate science.

    But despite our role as leaders in Antarctic science, Australian funding and logistics for Antarctic research hasn’t kept pace. Our single icebreaking vessel spends most of its time on resupply missions, restricting its use for actual science. And funding is often piecemeal, which makes it hard to plan the complex, multi-year efforts it takes to do research down on the ice.

    This week, we saw a welcome change. The federal parliamentary committee on Australia’s external territories delivered a report calling for a second icebreaking vessel and more reliable funding. It also urged the government to progress work on marine protected areas in east Antarctica as well as resume fishing patrols, due to concern over illegal or exploitative fishing.

    These measures are long overdue. For those of us who work and study on the ice continent, logistics and funding have long been a challenge. Illegal fishing in Antarctica must be stamped out, and a second vessel would support our ambitious, world-leading science.

    Why is Antarctic science so important?

    Antarctica is often out of sight, out of mind for many Australians. But what happens on the ice doesn’t stay there.

    For climate science, Antarctica matters a great deal. For decades, much of the concern about melting ice focused on the Arctic and Greenland, while Antarctica stayed relatively stable. But this is now changing. Sea ice is melting more quickly than in the past. Glacial ice is retreating. Increased melting will affect sea level rise and ocean currents.

    I study diseases such as the lethal strain of bird flu which has devastated bird and some mammals populations around the world. It recently reached Antarctica, where it killed large numbers of penguins, skuas, crabeater seals and more. I saw the devastation myself on my recent journey there.

    If this strain makes it to Australia – the last continent free of it – it could come from the south and devastate both Australian wildlife and poultry.

    To study these large and important changes, we need to be down there on the ice. It’s not an easy task. Keeping our bases functional means we need regular resupply missions. Repairs and extensions require tradies. Scientists and other workers need to be brought home.

    Antarctic science has long relied on just one vessel, now the RSV Nuniya, which the Australian Antarctic Division describes as the “main lifeline to Australia’s Antarctic and sub-Antarctic research stations and the central platform of our Antarctic and Southern Ocean scientific research”.

    The problem is, resupply can trump science. After all, no one wants bases running short of food or fuel. This is, in fact, what the Nuniya is largely doing.

    Australia’s role is key

    The Australian Antarctic Territory represents about 40% of the ice continent – the largest territory by far.

    Territory, here, doesn’t mean exclusive rights. In 1959, 12 nations with a scientific interest in the ice continent signed the Antarctic Treaty. This treaty was an agreement that Antarctica – the only landmass with no indigenous human presence – would be reserved for peaceful, scientific purposes.

    But in recent years, this treaty has come under pressure. Nations such as Norway and China have expanded fishing operations for krill. Illegal and unregulated fishing from various nations continues.

    The report recommends the Australian government continue efforts to establish a marine protected area off East Antarctica – where fishing would be restricted – as well as reopening fishing patrols. China – which recently opened its fifth Antarctic base – is opposed to the idea of fishing-free zones and is pushing to expand fishing in the Southern Ocean.

    Under Antarctica’s ice lie many resources. Mining is banned in Antarctica until 2048. What happens after that is uncertain. The race to tap critical minerals in Greenland signals what may lie ahead for Antarctica.

    This is why Australia’s leadership in Antarctic science matters. Australia was an original signatory to the Antarctic Treaty, and has a long history of exploration and science. Hobart has long been the home of Australia’s Antarctic vessels.

    As Antarctica changes, Australian scientists must be there to analyse, understand and report back. To do that, improvements are needed, including new vessels and longer-term funding. This report is the first step.

    The government is yet to formally respond to the report’s recommendations. Let’s hope it takes heed of the findings.

    Jane Younger receives funding from the Australian Research Council, WIRES Australia, the Geoffrey Evans Trust and the National Geographic Society.

    ref. Antarctic research has long been hamstrung by reliance on one icebreaker and sporadic funding. That might be about to change – https://theconversation.com/antarctic-research-has-long-been-hamstrung-by-reliance-on-one-icebreaker-and-sporadic-funding-that-might-be-about-to-change-249714

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI USA: RI Delegation Demands Answers from Trump’s Pick to Lead Commerce About DOGE Storming NOAA & Attempting to Downsize the Agency’s Critical Capabilities

    US Senate News:

    Source: United States Senator for Rhode Island Jack Reed

    WASHINGTON, DC – U.S. Senators Jack Reed and Sheldon Whitehouse along with Congressmen Seth Magaziner and Gabe Amo today sent a letter to President Trump’s pick to lead the U.S. Department of Commerce, demanding answers about the Trump Administration’s ongoing efforts to drastically reduce the National Oceanic and Atmospheric Administration’s (NOAA) workforce and budget. 

    NOAA is a critical federal agency charged with researching ocean systems, marine life, and the Earth’s climate; forecasting weather; monitoring atmospheric conditions; and mapping the seas; among other critical tasks.  The federal agency has its own fleet of research and survey vessels and specialized aircraft, operated by a combination of NOAA Corps officers and civilians.

    “We write to express concern about ongoing efforts to drastically reduce the National Oceanic and Atmospheric Administration’s (NOAA) workforce and budget.  These actions have severe consequences for Rhode Island and the nation, undermining NOAA’s ability to fulfill its vital mission of safeguarding our economy, environment, and national security,” Rhode Island’s Congressional delegation wrote to Howard Lutnick, who Trump picked to run the Commerce Department.

    The U.S. Senate is preparing to vote in the coming days on Mr. Lutnick’s nomination.  During his confirmation before the Senate Committee on Commerce, Science, and Transportation, Mr. Lutnick verbally pledged not to try and dismantle NOAA or break up and privatize the agency.  However, he then backtracked on that sentiment in his written responses to the committees questions: “During your January 29, 2025, nomination hearing before the Senate Committee on Commerce, Science, and Transportation, when asked if you agreed about a Project 2025 proposal suggesting NOAA should be dismantled, many of its functions eliminated, sent to other agencies, privatized, or placed under the control of states and territories, you responded with a simple: “No.”  However, when asked for the record whether NOAA should be dismantled, you wrote: “It is premature to discuss any specific recommendations,” the four members of Rhode Island’s Congressional delegation wrote. 

    Recent press reports indicate that the Trump Administration is already taking steps to downsize and degrade NOAA’s ability to carry out its core missions and that staffers from the so-called DOGE task force have already entered NOAA facilities, locked out career staff, and demanded access to sensitive information technology systems.

    “We are alarmed by recent reports that staffers from the Department of Government Efficiency (DOGE) have been given access to NOAA’s offices and that NOAA employees have been told to expect a 50% reduction in staff and budget cuts of 30%.  If carried out, these threats will have real impacts for our constituents – undermining NOAA’s ability to provide accurate, timely, and free weather forecasts, putting lives at risk during hurricanes and other severe weather events, and have ripple effects on national defense, emergency response, and economic stability,” the four lawmakers wrote.

    NOAA has a strong presence in Rhode Island, thanks in part to Senator Reed’s successful effort to bring Marine Operations Center – Atlantic (MOC-A) to Naval Station Newport.  Construction of the $150 million shoreside NOAA hub and complimentary pier infrastructure has been underway for over a year and is expected to be completed in 2027.

    The delegation’s letter also notes that NOAA services play a critical role in coastal and marine research, fisheries management, weather forecasting, and climate monitoring.  These services are particularly important in Rhode Island, where the Blue Economy is a major driver of jobs and economic growth. 

    Full text of the letter follows:

    February 11, 2025

    The Honorable Howard Lutnick

    Chairman and CEO 

    Cantor Fitzgerald, L.P.

    110 East 59th Street

    New York, NY 10022

    Dear Mr. Lutnick:

    We write to express concern about ongoing efforts to drastically reduce the National Oceanic and Atmospheric Administration’s (NOAA) workforce and budget.  These actions have severe consequences for Rhode Island and the nation, undermining NOAA’s ability to fulfill its vital mission of safeguarding our economy, environment, and national security.

    NOAA services play a critical role in coastal and marine research, fisheries management, weather forecasting, and climate monitoring.  These services are particularly important in Rhode Island, where the blue economy is a major driver of jobs and economic growth.  Further, NOAA’s aviation weather services are critical for air travel safety, and its oceanographic research supports the U.S. Navy and Coast Guard in ensuring maritime security, detecting underwater threats, and advancing strategic ocean intelligence.  

    We are alarmed by recent reports that staffers from the Department of Government Efficiency (DOGE) have been given access to NOAA’s offices and that NOAA employees have been told to expect a 50% reduction in staff and budget cuts of 30%.  If carried out, these threats will have real impacts for our constituents – undermining NOAA’s ability to provide accurate, timely, and free weather forecasts, putting lives at risk during hurricanes and other severe weather events, and have ripple effects on national defense, emergency response, and economic stability.

    During your January 29, 2025, nomination hearing before the Senate Committee on Commerce, Science, and Transportation, when asked if you agreed about a Project 2025 proposal suggesting NOAA should be dismantled, many of its functions eliminated, sent to other agencies, privatized, or placed under the control of states and territories, you responded with a simple: “No.”  However, when asked for the record whether NOAA should be dismantled, you wrote: “It is premature to discuss any specific recommendations.”  

    In order to fully understand your plans and objectives if confirmed as Secretary of Commerce, we ask that you clarify your response to these critical questions and how, if confirmed as Secretary, you would uphold NOAA’s congressionally-mandated service.

    Thank you in advance for your attention to this important matter.  We look forward to your prompt response.

    Sincerely,

    MIL OSI USA News

  • MIL-OSI USA: On Senate Floor, Shaheen Speaks Out Against the Confirmation of Robert F. Kennedy Jr. for Health and Human Services Secretary

    US Senate News:

    Source: United States Senator for New Hampshire Jeanne Shaheen

    (Washington, DC) – Today, U.S. Senator Jeanne Shaheen (D-NH) delivered remarks on the floor of the U.S. Senate to oppose the confirmation of Robert F. Kennedy, Jr., for Health and Human Services Secretary. In her remarks, Shaheen highlighted Kennedy’s troubling record of promoting conspiracy theories that put lives at risk, supporting efforts to defund critical public health programs and denying scientific consensus on public health. You can watch her speech in full here. 

    Key Quotes: 

    • “We should be taking steps right now to lower costs for families and children. Half of uninsured Granite Staters cite cost as their reason for not purchasing health coverage. More than two-thirds of [uninsured] people in New Hampshire have delayed care and another 25 percent have delayed buying needed prescriptions or said they have to ration their meds.” 
    • “This decision by the Trump Administration [to cut NIH funding] will cut Dartmouth’s funding by $38 million and we don’t know what future impact that would be. Will we miss the next cure for a pediatric cancer? Will we fail to advance treatments in Alzheimer’s? What we do know is that […] the job loss [and] the economic impact that will result from this decision will be devastating.”   
    • “Women in this country need to know that the Secretary of Health and Human Services will defend our rights to access all the health care we need. But at every turn, Republicans and the Trump Administration have pushed forward dangerous policies intended to threaten access to full reproductive care.” 
    • “America deserves a leader at HHS who values science, who protects public health, who defends women’s rights to reproductive care—to the full range of reproductive care—and who upholds the integrity of our country’s core health systems. RFK Jr. has shown time and again that he is not that leader. His dangerous rhetoric on vaccines, his reckless plans to gut critical agencies and lack of understanding of basic health care make him uniquely unqualified to advance the well-being of all Americans.”  

    Full Remarks as Delivered: 

    ???  

    Mr. President. I come to the floor to join my colleagues with a great deal of concern to discuss the Trump Administration’s nomination of Robert F. Kennedy, Jr., to be the next Secretary of the Department of Health and Human Services. 

    To put it very simply at the outset, Robert F. Kennedy—RFK Jr.—is unfit to lead the highest health office in our nation.  

    First of all, RFK has no—let me repeat, no—health or medical experience.  

    That in it of itself should be a red flag on this nominee who is supposed to be tasked with leading our nation’s health agency. 

    But sadly, that’s not where the red flags end. 

    From his radical and dangerous opinions on vaccines and public health, to his promises to cut medical research to his ever-changing position on women’s rights to access reproductive health care, he has proven that he lacks the credibility, the knowledge and the capability to be Secretary of Health and Human Services.  

    So, let’s take a step back.  

    When the President ran his campaign, he ran a campaign on lowering costs for working Americans. Well, where has that promise gone?  

    We saw today that inflation has gone up in the last quarter. It’s over 3 percent now. 

    And we’ve seen nothing from President Trump’s first weeks in office that addresses the high costs of health care, of food, of housing, of child care.  

    Two weeks ago, this Administration, including the Health and Human Services agency, halted funding across the board for programs like our community health centers and substance use treatment programs.  

    These centers are often the main source of health care for their community. They serve the people across the states of this country. 

    In our office, I heard from programs like Coos County Family Heath, a community health center that provides life-saving care to rural patients across the North Country of New Hampshire—what we call the North Country. 

    Their programs for training new doctors and providing services for victims of domestic violence were, and still are, at risk thanks to Trump’s executive orders and funding freeze.  

    And I heard from Navigating Recovery in Laconia, that’s a substance use treatment service that depends on federal funding for more than 50 percent of its budget. They’re worried about keeping their doors open.  

    And this is an organization with providers who will literally sit with a patient by their hospital bed following an overdose to make sure they’re getting the best guidance, the best treatment and the follow on services like housing and child care that allows them to start their recovery. 

    And this is a real issue for us in New Hampshire, where we’ve been hit very hard by the opioid epidemic. 

    The Trump executive orders and funding cuts will force Navigating Recovery to lay off staff and to curtail services should those funding cuts continue. 

    These are actions on the part of the White House that don’t lower costs for families – they do just the opposite. 

    They put people out of work and weaken our ability to care for our most vulnerable populations.  

    But when he was asked if he would reverse this policy, of cutting funding for programs like substance use recovery, RFK refused.  

    The thing is, we should be taking steps right now to lower costs for families and children.  

    Half of uninsured Granite Staters cite cost as their reason for not purchasing health coverage.   

    More than two-thirds of [uninsured] people in New Hampshire have delayed care, and another 25 percent have delayed buying needed prescriptions or said they have to ration their meds.   

    We could help these people right now.  

    We could pass the Health Care Affordability Act, which would make permanent premium tax credits in the Affordable Care Act that have cut health care costs for 24 million Americans—nearly 70,000 from New Hampshire. 

    Passing that bill would directly help constituents like the man in Newmarket who contacted our office. 

    He’s 55 years old, he’s a patient at Lamprey Health Care, which is a community health center.  

    He had been uninsured and avoided going to a doctor his whole life.  

    But sadly, he was recently hospitalized for 10 days because of complications from untreated diabetes. He had sepsis and he had an infection in his foot.  

    Unfortunately, he didn’t have insurance when he was hospitalized.  

    But luckily, Lamprey Health sat with him, helped him purchase insurance on HealthCare.gov, helping avoid potentially devastating medical debt.  

    These tax credits are vital to his and to millions of Americans’ ability to afford care.  

    But again, when asked about these tax credits, RFK refused to say that he would support extending them.  

    So much for lowering costs to families.  

    Now, if this Administration is not trying to lower costs, what are they doing to help the people they swore an oath to serve? 

    Last Friday, our research institutions got a notification, almost overnight, that their funding through the National Institutes of Health would be gutted. 

    This decision threatens our ability to find cures for diseases, to get ahead of public health crises and to hire and retain talent. 

    I think it was made rashly and irresponsibly without really understanding what the impact would be. 

    Slashing those funds won’t make research more efficient; instead, it’s going to cripple our ability to treat and cure horrific diseases.  

    Dartmouth College, which is in Hanover, New Hampshire, is one of our preeminent research institutions in the country.  

    Last year, Dartmouth received nearly $100 million in NIH funding to help with its cutting-edge research to treat diseases like diabetes, cystic fibrosis and Alzheimer’s. 

    This NIH decision—this decision by the Trump Administration—will cut Dartmouth’s funding by $38 million, and we don’t know what future impact that would be. 

    Will we miss the next cure for a pediatric cancer?  

    Will we fail to advance treatments in Alzheimer’s?  

    What we do know is that this has an immediate impact on the people living in the Upper Valley of New Hampshire.  

    More than 1,300 employees are supported by federal grants at Dartmouth, and the vast majority of these are supported by the National Institutes of Health.  

    The job loss, the economic impact that will result from this decision will be devastating.  

    And sadly, once those jobs are gone, and the researchers leave, there’s no going back because they’re going someplace else, they’re going overseas. 

    But we unfortunately know RFK that supports this decision, because he has publicly supported gutting NIH staff and research.  

    And if, RFK is confirmed, I fear he will do nothing to push back or to reverse these reckless decisions.   

    The Secretary of HHS also holds immense power over ensuring that women in our country have the ability to access reproductive health services, including abortion.  

    Interestingly, I thought this was something that RFK and I agreed on.  

    But now, I’m not clear what he supports.  

    He used to proudly say that he was pro-choice. But since being nominated, that belief seems to have disappeared overnight.  

    The only thing I think he truly believes is in his desire to do whatever Trump wants, even if it means compromising his own values. 

    Women in this country need to know that the Secretary of Health and Human Services will defend our rights to access all the health care we need. 

    But at every turn, Republicans and the Trump Administration have pushed forward dangerous policies intended to threaten access to full reproductive care. 

    They put onto the Supreme Court the justices who overturned Roe v. Wade.  

    At the state level, they have instituted draconian abortion bans that threaten the lives of mothers. 

    Women are literally dying—dying—from a lack of care because of these bans on our health.  

    This is 2025. How did we get here?  

    I remember before Roe v Wade. I remember when hundreds of thousands of women died from back alley abortions. And are we back to that point? 

    Everyone knows that banning abortion and making women seek dangerous options does not stop abortions, it makes them more deadly.  

    But with RFK at the helm, that’s the grim reality we face. 

    He’s not someone I trust to defend a woman’s right to access reproductive health care. He is not someone I want leading Health and Human Services. 

    Now, one of the few issues we have some actual insight into are his views on public health.  

    His dangerous, radical and wrong beliefs about vaccines are well documented.  

    Every child that gets sick or dies from a disease that could be prevented by a vaccine is a tragedy.  

    RFK will not only undermine public confidence in vaccines, he indicated that he intends to continue to profit from anti-vaccine lawsuits.  

    It’s shameful and it’s corrupt. 

    Now, we’ve also heard reports that the Trump administration plans to cut as much as 50 percent of Health and Human Services staff and decimate the Centers for Disease Control and Prevention.  

    The CDC is our first line of defense for public health, most important, tracking and responding to outbreaks of diseases not only domestically but abroad as well.  

    The Trump Administration has already taken steps to gut out global health and aid efforts, from withdrawing from the World Health Organization, to cutting the CDC and U.S. Agency for International Development. 

    They argue that these efforts are wasteful and unnecessary.  

    But just last Friday, we were notified in New Hampshire that we had only the third confirmed case ever in the U.S. of clade 1 Monkey Pox—or Mpox.  

    The case is travel-related, meaning the patient caught the disease abroad and brought it home.  

    Sadly, these things, these diseases don’t just stop at countries’ border. They don’t just happen overseas. They affect us here at home.  

    The Trump Administration’s efforts to eliminate our public health infrastructure doesn’t make America safer, it doesn’t make America stronger and it doesn’t make America more prosperous. It does the exact opposite. 

    And Robert F. Kennedy Jr. is complicit. He’s complicit in these efforts, and he will only continue them should he be confirmed.  

    America deserves a leader at HHS who values science, who protects public health, who defends women’s rights to reproductive care—to the full range of reproductive care—and who upholds the integrity of our country’s core health systems.  

    RFK Jr. has shown time and again that he is not that leader.  

    His dangerous rhetoric on vaccines, his reckless plans to gut critical agencies and lack of understanding of basic health care make him uniquely unqualified to advance the well-being of all Americans.  

    I urge my colleagues to reject his nomination for Secretary of Health and Human Services.   

    MIL OSI USA News

  • MIL-OSI USA: Cassidy, Daines, Colleagues Introduce Bill to Stop Ban of Traditional Ammo, Tackle

    US Senate News:

    Source: United States Senator for Louisiana Bill Cassidy
    WASHINGTON – U.S. Senators Bill Cassidy, M.D. (R-LA), Steve Daines (R-MT), and 26 Republican colleagues introduced legislation to prohibit the U.S. Fish and Wildlife Service (USFWS), the U.S. Bureau of Land Management (BLM), and the U.S. Forest Service (USFS) from banning the use of lead ammunition or tackle on public lands unless such action is supported by the best available science.
    “Louisiana is known as Sportsman’s Paradise for a reason,” said Dr. Cassidy. “Federal bureaucrats who have never hunted or fished a day in their life should have no say in how our outdoorsmen enjoy our state.”
    “The great outdoors is a staple of our Montana way of life. Montana hunters and anglers play an important role in wildlife management, and a ban on lead ammo and tackle would be unfair to our sportsmen. I’ll keep fighting with my colleagues to make sure decisions impacting outdoor recreation are guided by commonsense science, not anti-hunting groups,” said Senator Daines. 
    Cassidy and Daines were joined by U.S. Senators John Thune (R-SD), Jerry Moran (R-KS), Dan Sullivan (R-AK), Thom Tillis (R-NC), Mike Crapo (R-ID), Jim Risch (R-ID), Cynthia Lummis (R-WY), John Barrasso (R-WY), Rick Scott (R-FL), James Lankford (R-OK), Tommy Tuberville (R-AL), Mike Lee (R-UT), John Boozman (R-AR), Roger Marshall (R-KS), Marsha Blackburn (R-TN), Roger Wicker (R-MS), Deb Fischer (R-NE), Tim Sheehy (R-MT), Mike Rounds (R-SD), Katie Britt (R-AL), Kevin Cramer (R-ND), Tom Cotton (R-AR), Jim Justice (R-WV), Bill Hagerty (R-TN), John Hoeven (R-ND), and Cindy Hyde-Smith (R-MS) in introducing the bill.

    MIL OSI USA News

  • MIL-OSI USA: Tuberville, Daines Fight for Outdoorsmen Across the Country

    US Senate News:

    Source: United States Senator Tommy Tuberville (Alabama)
    WASHINGTON – Today, U.S. Senator Tommy Tuberville (R-AL) joined U.S. Senator Steve Daines (R-MT) in cosponsoring a bill to prohibit the U.S. Fish and Wildlife Service (USFWS), the Bureau of Land Management (BLM), and the U.S. Forest Service (USFS) from banning the use of lead ammunition or tackle on public lands unless such action is supported by the best available science—the Protecting Access for Hunters and Anglers Act. 
    Sen. Tuberville cosponsored this legislation last Congress.
    “From Sand Mountain to the Gulf of America, Alabamians devote a large portion of their free time to hunting in the great outdoors,” said Sen. Tuberville. “Placing a ban on lead ammo and tackle is unfair to those who choose to enjoy nature and wildlife. As an avid outdoorsman, I will keep fighting to ensure the rights of Alabama hunters and anglers are protected.”
    “The great outdoors is a staple of our Montana way of life. Montana hunters and anglers play an important role in wildlife management, and a ban on lead ammo and tackle would be unfair to our sportsmen. I’ll keep fighting with my colleagues to make sure decisions impacting outdoor recreation are guided by commonsense science, not anti-hunting groups,” said Sen. Daines.
    U.S. Senators Tuberville and Daines are joined by U.S. Senators John Barrasso (R-WY), Marsha Blackburn (R-TN), John Boozman (R-AR), Katie Britt (R-AL), Bill Cassidy (R-LA), Tom Cotton (R-AR), Kevin Cramer (R-ND), Mike Crapo (R-ID), Deb Fischer (R-NE), Bill Hagerty (R-TN), John Hoeven (R-ND), Cindy Hyde-Smith (R-MS), Jim Justice (R-WV), James Lankford (R-OK), Mike Lee (R-UT), Cynthia Lummis (R-WY), Roger Marshall (R-KS), Jerry Moran (R-KS), Jim Risch (R-IN), Mike Rounds (R-SD), Rick Scott (R-FL), Dan Sullivan (R-AK), Thom Tillis (R-NC), John Thune (R-SD), and Roger Wicker (R-MS) in cosponsoring the legislation. 
    Read full text of the legislation here.
    Senator Tommy Tuberville represents Alabama in the United States Senate and is a member of the Senate Armed Services, Agriculture, Veterans’ Affairs, HELP, and Aging Committees.

    MIL OSI USA News

  • MIL-OSI China: New fish species discovered in South China Sea

    Source: China State Council Information Office 2

    A Chinese research team has discovered a new fish species, named Mononoke tilefish (Branchiostegus sanae), in South China Sea.
    The findings were published Wednesday in the international taxonomic journal Zookeys.
    Researchers from the Chinese Academy of Sciences’ South China Sea Institute of Oceanology, Zhejiang University, and Ocean University of China identified the new species in the continental slope area between Hainan Island and Xisha Qundao at a depth of about 200 meters.
    Huang Haochen, first author of the study, said that the new species, like other deepwater tilefish, is an economically significant species. Despite their culinary value, limited scientific research has been conducted on these deep-dwelling fish.
    Known locally as “ghost horsehead fish” due to its distinctive head shape, this new species has long been recognized by fishermen along the South China Sea coast. Researchers collected specimens in 2023, enabling detailed study.
    Mononoke tilefish exhibits significant morphological and genetic differences from other tilefish species. While all known specimens were collected between Hainan’s Lingshui Li Autonomous County and Xisha Qundao, the new species is believed to inhabit the northwestern slope regions of the South China Sea, according to Chen Jingxuan, second author of the study.
    With this discovery, the number of known tilefish species in Chinese waters has risen to six. The Mononoke tilefish, which can exceed 40 centimeters in length, represents a rare find of a medium-to-large fish species in recent years. Further research into its biology and evolutionary history is expected to contribute to the conservation of local biodiversity and sustainable fisheries. 

    MIL OSI China News

  • MIL-Evening Report: ‘A house battery you can drive around’: how a handful of Australians are selling power from their cars back to the grid

    Source: The Conversation (Au and NZ) – By Scott Dwyer, Research Director, Energy Futures, University of Technology Sydney

    24K-Productions

    Our cars sit unused most of the time. If you have an electric vehicle, you might leave it charging at home or work after driving it. But there’s another step you could take. If you have a bidirectional charger, you can set it to sell power back to the grid when demand is high.

    Fewer than ten people across Australia actually do this, because the technology – known as Vehicle-to-Grid (V2G) – is very new. To date, it only works with a single car model (Nissan LEAF) and a single charger (Wallbox Quasar 1). We’ve estimated the number of users based on sales of this charger. The chargers are expensive and there’s a thicket of regulations to navigate.

    But that could soon change. Last year, Climate Change Minister Chris Bowen announced new Australian standards and communications protocols for bidirectional chargers in a bid to make it mainstream. Cheaper EVs and bidirectional chargers will make this more appealing.

    If it takes off, V2G could become extremely useful to the power grid as a way to release power as required and stabilise the grid against fluctuations.

    This week, Australia’s renewable energy agency released a V2G roadmap, which notes widespread uptake could “materially reduce electricity costs for consumers and accelerate national emissions reduction”.

    To understand why people are using the technology and the challenges to do so, we interviewed five early adopters from New South Wales and South Australia. Our findings are released today.

    A bidirectional charger is necessary to sell power back to the grid.
    doublelee/Shutterstock

    Setting up V2G isn’t easy

    Our interviewees reported a long, complex journey to set up V2G. These early adopters had no playbook to follow, so the process was one of trial and error.

    Some relied on professional networks or social media groups to gather information. They spent significant time and energy finding electricians, installers and charger manufacturers to set up their systems. Strata approvals were required. They also had to negotiate with power retailers and distributors.

    Delays were common, especially when seeking approval from the energy distributor. Some interviewees reported delays of months to years.

    Most interviewees had experience in a technical field such as engineering or technology. Some reported a significant learning curve, while others using new software from their retailer reported a smoother “set and forget” process.

    So why do it? Our interviewees had several reasons, ranging from getting the most out of expensive assets (solar and the EV) to offsetting power bills entirely.

    Four out of five interviewees reported making a small profit of about A$1,000 annually instead of a bill. Many wanted to be able to reduce dependence on the grid and reduce their environmental impact.

    As one told us:

    you originally think of it as a car you can also use to power your house. [But actually] it’s a house battery you can drive around.

    Maximising savings

    Typically, our interviewees plugged their car in at home during the day to charge from their rooftop solar. In the evenings when power prices peaked, they used an app to sell power back to the grid. This maximised their cost savings for charging the car battery and their earnings from the grid.

    For instance, a V2G user was alerted by their energy retailer that power prices had spiked to over $20 per kilowatt hour – far above normal rates of 25–45 cents. They immediately set their car and home battery to sell power back to the grid. In two hours, they sold 28 kilowatt hours of power to the grid and made more than $560. As they told us: “I look forward to more such events.”

    Our interviewees often monitored energy prices, solar output and car battery levels to optimise their output. To avoid their EV battery getting too low, they set a lower limit – say 30% of charge – after which their car would stop exporting power.

    This photo shows the setup of one of our early adopter interviewees. Pictured is the Nissan LEAF and bidirectional charger. For years, this has been the only car model compatible with vehicle to grid, but this is set to change.
    Author provided, CC BY-NC-ND

    Is there a downside?

    One of the main reasons people are sceptical of V2G is due to concern about accelerated degradation of the battery.

    This is a common concern. But to date, there’s no consensus showing V2G shortens the battery life of EVs significantly. One recent study shows it increases degradation by 0.3% a year. But another showed V2G might actually extend battery life in some scenarios.

    Last year, we surveyed more than 1,300 members of a motoring organisation about their view of V2G technology. We found battery warranty was a bigger concern than battery life. This is because most EV manufacturers other than Nissan don’t mention V2G in their battery warranties, leading drivers to believe they might void their warranty by using V2G.

    Awareness of V2G technology is growing. The survey also found almost 40% of respondents were very or somewhat familiar with V2G, a jump from the 17% who reported familiarity in 2022. Among EV owners, almost 90% reported knowledge of the concept.

    Moving beyond early adopters

    For V2G to go mainstream, the process must be much simpler, cheaper and easier to set up.

    To accelerate uptake, reliable, accessible information is essential.

    Expanding government incentive programs to include bidirectional chargers would cut the upfront cost and make it more accessible.

    Even within the EV supply chain, knowledge of V2G is limited. Car dealerships will need to know which models work with V2G.

    Electricians may need specific training to install and maintain these chargers.

    EVs are falling in price as manufacturers vie for market share and cheaper options become available. V2G capabilities might help boost sales for competing car companies.

    As more motorists switch to EVs, interest in V2G will increase. While V2G can boost the appeal of EVs, there are others, such as Vehicle-to-Home (using your car to power your home during blackouts or to save money) and Vehicle-to-Load (using your EV to run power tools or appliances).

    Each of these can help consumers get more value from the vehicles parked in driveways and garages.

    Scott Dwyer receives funding from iMOVE Australia Cooperative Research Centre and the NRMA for this project.

    Scott Dwyer receives funding from iMOVE Australia Cooperative Research Centre and the NRMA for this project.

    Kriti Nagrath receives funding from iMOVE Australia Cooperative Research Centre and the NRMA for this project.

    ref. ‘A house battery you can drive around’: how a handful of Australians are selling power from their cars back to the grid – https://theconversation.com/a-house-battery-you-can-drive-around-how-a-handful-of-australians-are-selling-power-from-their-cars-back-to-the-grid-249696

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI USA: Warren, Markey Slam Trump Administration for Causing “Chaos and Upheaval” at Massachusetts Research Institutions, Demand Answers from NIH and NSF

    US Senate News:

    Source: United States Senator for Massachusetts – Elizabeth Warren
    February 12, 2025
    “Trump Administration actions are endangering life-saving research and economic growth in Massachusetts and across the country.”
    “The chaos caused by the Trump administration is unacceptable—and you owe researchers and patients in Massachusetts and beyond an explanation about what is going on at your agencies.” 
    Text of Letter (PDF) 
    Washington, D.C. – U.S. Senators Elizabeth Warren (D-Mass.) and Edward J. Markey (D-Mass.) wrote to the National Institutes of Health (NIH) and the National Science Foundation (NSF) with concerns about the ongoing Trump Administration funding cuts at Massachusetts research institutions. 
    The NIH and NSF are the largest public funders of research in the United States — fueling the development of lifesaving treatments for diseases like cancer, heart disease, and diabetes, tools for the early detection of Alzheimer’s disease, and more. This funding is particularly indispensable in Massachusetts, where dozens of world-renowned universities, hospitals, and research institutions rely on NIH and NSF grants to support cutting-edge research that benefits the U.S. economy and patients around the world.
    Within days of taking office, the Trump Administration called for an immediate pause on all public communications from HHS, NIH’s parent organization, and one week later, paused all activities related to the disbursement of funds. This pause was blocked by a federal judge, but the Trump administration has refused to fully comply with the order to unfreeze funds. 
    On February 7, the NIH announced that all new and existing research awards would face major cuts, due to reduction in the “indirect cost rate.” Following a legal challenge by 22 state attorneys general, led by Massachusetts Attorney General Campbell, a federal judge issued a temporary order blocking the cut within those states. Still, researchers, students, and institutions are facing huge budget cuts and continued uncertainty.
    These “Trump Administration actions are endangering life-saving research and economic growth in Massachusetts and across the country,” wrote the lawmakers. 
    “The chaos caused by the Trump administration is unacceptable—and you owe researchers and patients in Massachusetts and beyond an explanation about what is going on at your agencies,” continued the lawmakers.
    The Senators’ offices conducted interviews with institutions who are among the top recipients of NIH and NSF funding in Massachusetts about the impact these cuts would have on researchers’ projects, careers, and on the local economy. These interviews revealed that: 
    The funding freezes and cuts at NIH and NSF have caused chaos and confusion at Massachusetts research institutions. Representatives at Massachusetts research institutions described a “hunger for clear guidance on what is impacted and what isn’t” as investigators scramble to save their work and plan for the years and months ahead. They are concerned about existing grants being clawed back, afraid to ask for clarification for fear they’ll have a “target on their back,” and in some instances even unable to “buy a book or a pencil.” 
    The funding cut offs are impeding research carried out by Massachusetts institutions that enable critical, lifesaving care. NIH and NSF funding saves Americans’ lives by sponsoring life-saving clinical trials, many of which are conducted at Massachusetts institutions. Thus, for some, the consequences of the funding pauses could be life or death: “if you’re a cancer patient in a clinical trial, it is not a theoretical undertaking, it is treatment.”
    Federal funding disruptions at Massachusetts institutions puts the future of a highly skilled STEM workforce at risk.Nearly half of all science and engineering doctoral recipients graduating from U.S. research institutions have received federal research funding during their graduate studies. According to conversations with Massachusetts research institution representatives, “higher education is a big industry in Massachusetts, we’re training the workforce at every level;” pulling back this funding risks “a situation where you can only earn a PhD if you’re already wealthy.” 
    Freezes and cuts in federal research funding at Massachusetts institutions will be a critical hit to the innovation that has cemented the United States as a vanguard in healthcare.Massachusetts scientists are using NIH grants to create new cancer drugs; develop new technologies—like the bionic pancreas—to treat disease; study ways to combat the opioid epidemic; and identify risk factors for heart disease, among other critical endeavors. As representatives from Massachusetts-based research institutions said, “if anyone in the world has a serious disease and they want to come to the US – they want to come to Boston.” 
    Federal funding disruptions will harm the Massachusetts and United States economies.The NIH is the largest single public funder of biomedical and behavioral research in the world, and in fiscal year 2023 NIH funding generated over $90 billion in economic activity in the United States. In Massachusetts along that same year, the NIH awarded $3.5 billion in grants in contracts that directly supported 28,842 jobs and nearly $7.5 billion in economic activity. 
    “The unprecedented actions taken by the Trump Administration will undermine the United States’ research edge—whether through abandoned research projects, staffing shortages, or a “brain drain” in our biotech workforce as young, budding scientists opt for other careers and countries with greater certainty,” concluded the lawmakers. 
    The senators urged the agencies to end the funding freeze and threats to cut grant expenditures and provide clarity on their directive-issuing processes and the rationale behind the indirect cost cap reduction by February 26, 2025. In 2017, following President Trump’s budget proposal seeking massive cuts to the NIH, Senator Warren released a report detailing the importance of NIH funding to Massachusetts. 

    MIL OSI USA News

  • MIL-Evening Report: ‘It’s a house battery you can drive around’ – how a handful of Australians are selling power back to the grid from their cars

    Source: The Conversation (Au and NZ) – By Scott Dwyer, Research Director, Energy Futures, University of Technology Sydney

    24K-Productions

    Our cars sit unused most of the time. If you have an electric vehicle, you might leave it charging at home or work after driving it. But there’s another step you could take. If you have a bidirectional charger, you can set it to sell power back to the grid when demand is high.

    Fewer than ten people across Australia actually do this, because the technology – known as Vehicle-to-Grid (V2G) – is very new. To date, it only works with a single car model (Nissan LEAF) and a single charger (Wallbox Quasar 1). We’ve estimated the number of users based on sales of this charger. The chargers are expensive and there’s a thicket of regulations to navigate.

    But that could soon change. Last year, Climate Change Minister Chris Bowen announced new Australian standards and communications protocols for bidirectional chargers in a bid to make it mainstream. Cheaper EVs and bidirectional chargers will make this more appealing.

    If it takes off, V2G could become extremely useful to the power grid as a way to release power as required and stabilise the grid against fluctuations.

    This week, Australia’s renewable energy agency released a V2G roadmap, which notes widespread uptake could “materially reduce electricity costs for consumers and accelerate national emissions reduction”.

    To understand why people are using the technology and the challenges to do so, we interviewed five early adopters from New South Wales and South Australia. Our findings are released today.

    A bidirectional charger is necessary to sell power back to the grid.
    doublelee/Shutterstock

    Setting up V2G isn’t easy

    Our interviewees reported a long, complex journey to set up V2G. These early adopters had no playbook to follow, so the process was one of trial and error.

    Some relied on professional networks or social media groups to gather information. They spent significant time and energy finding electricians, installers and charger manufacturers to set up their systems. Strata approvals were required. They also had to negotiate with power retailers and distributors.

    Delays were common, especially when seeking approval from the energy distributor. Some interviewees reported delays of months to years.

    Most interviewees had experience in a technical field such as engineering or technology. Some reported a significant learning curve, while others using new software from their retailer reported a smoother “set and forget” process.

    So why do it? Our interviewees had several reasons, ranging from getting the most out of expensive assets (solar and the EV) to offsetting power bills entirely.

    Four out of five interviewees reported making a small profit of about A$1,000 annually instead of a bill. Many wanted to be able to reduce dependence on the grid and reduce their environmental impact.

    As one told us:

    you originally think of it as a car you can also use to power your house. [But actually] it’s a house battery you can drive around.

    Maximising savings

    Typically, our interviewees plugged their car in at home during the day to charge from their rooftop solar. In the evenings when power prices peaked, they used an app to sell power back to the grid. This maximised their cost savings for charging the car battery and their earnings from the grid.

    For instance, a V2G user was alerted by their energy retailer that power prices had spiked to over $20 per kilowatt hour – far above normal rates of 25–45 cents. They immediately set their car and home battery to sell power back to the grid. In two hours, they sold 28 kilowatt hours of power to the grid and made more than $560. As they told us: “I look forward to more such events.”

    Our interviewees often monitored energy prices, solar output and car battery levels to optimise their output. To avoid their EV battery getting too low, they set a lower limit – say 30% of charge – after which their car would stop exporting power.

    This photo shows the setup of one of our early adopter interviewees. Pictured is the Nissan LEAF and bidirectional charger. For years, this has been the only car model compatible with vehicle to grid, but this is set to change.
    Author provided, CC BY-NC-ND

    Is there a downside?

    One of the main reasons people are sceptical of V2G is due to concern about accelerated degradation of the battery.

    This is a common concern. But to date, there’s no consensus showing V2G shortens the battery life of EVs significantly. One recent study shows it increases degradation by 0.3% a year. But another showed V2G might actually extend battery life in some scenarios.

    Last year, we surveyed more than 1,300 members of a motoring organisation about their view of V2G technology. We found battery warranty was a bigger concern than battery life. This is because most EV manufacturers other than Nissan don’t mention V2G in their battery warranties, leading drivers to believe they might void their warranty by using V2G.

    Awareness of V2G technology is growing. The survey also found almost 40% of respondents were very or somewhat familiar with V2G, a jump from the 17% who reported familiarity in 2022. Among EV owners, almost 90% reported knowledge of the concept.

    Moving beyond early adopters

    For V2G to go mainstream, the process must be much simpler, cheaper and easier to set up.

    To accelerate uptake, reliable, accessible information is essential.

    Expanding government incentive programs to include bidirectional chargers would cut the upfront cost and make it more accessible.

    Even within the EV supply chain, knowledge of V2G is limited. Car dealerships will need to know which models work with V2G.

    Electricians may need specific training to install and maintain these chargers.

    EVs are falling in price as manufacturers vie for market share and cheaper options become available. V2G capabilities might help boost sales for competing car companies.

    As more motorists switch to EVs, interest in V2G will increase. While V2G can boost the appeal of EVs, there are others, such as Vehicle-to-Home (using your car to power your home during blackouts or to save money) and Vehicle-to-Load (using your EV to run power tools or appliances).

    Each of these can help consumers get more value from the vehicles parked in driveways and garages.

    Scott Dwyer receives funding from iMOVE Australia Cooperative Research Centre and the NRMA for this project.

    Scott Dwyer receives funding from iMOVE Australia Cooperative Research Centre and the NRMA for this project.

    Kriti Nagrath receives funding from iMOVE Australia Cooperative Research Centre and the NRMA for this project.

    ref. ‘It’s a house battery you can drive around’ – how a handful of Australians are selling power back to the grid from their cars – https://theconversation.com/its-a-house-battery-you-can-drive-around-how-a-handful-of-australians-are-selling-power-back-to-the-grid-from-their-cars-249696

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI USA: Grassley, Cantwell Reintroduce Bills to Lower Prescription Drug Prices, Drive PBM Accountability

    US Senate News:

    Source: United States Senator for Iowa Chuck Grassley
    WASHINGTON – Sen. Chuck Grassley (R-Iowa), Chairman of the Senate Judiciary Committee and former Chairman of the Senate Finance Committee, and Sen. Maria Cantwell (D-Wash.), Ranking Member of the Senate Commerce Committee, are reintroducing two bipartisan bills to combat the high cost of prescription drugs and provide greater transparency of pharmacy benefit managers (PBMs).
    “Iowans are fed up with the skyrocketing cost of prescription drugs and eager for Congress to act to put a stop to pharmacy benefit managers’ shady practices. These bipartisan legislative solutions will bring much-needed transparency to prescription drug pricing and ensure the federal government can effectively target the abusive practices that unfairly drive up drug costs,” Grassley said.  
    “For too long, Americans have been left in the dark while PBMs – the mysterious middlemen – manipulate prescription drug prices. We need to hold PBMs accountable for skyrocketing drug costs. With these bipartisan bills, I’m continuing to fight for accountability and transparency in the drug market so we can shine a light on unfair practices and make sure patients get a fair deal on the medications they need,” Cantwell said.
    Prescription Pricing for the People Act:
    This bill requires the Federal Trade Commission (FTC) to complete a 6(b) study examining the effects of consolidation on pricing in the PBM industry, as well as other potentially abusive behavior by PBMs. The bill instructs the FTC to provide policy recommendations to Congress to improve competition and protect consumers.
    Grassley has welcomed the FTC’s interim staff reports on opaque PBM practices. The interim staff reports are a direct result of Grassley’s prior requests for a 6(b) study on potential anti-competitive practices in the prescription drug industry, as well as his bipartisan demands for a status update in light of FTC’s significant delays. Once passed, this legislation will bring the FTC 6(b) study to completion. The bill falls within the jurisdiction of the Senate Judiciary Committee.
    Additional cosponsors are Sens. Roger Marshall (R-Kan.), Peter Welch (D-Vt.), Tommy Tuberville (R-Ala.), Chris Coons (D-Del.), Thom Tillis (R-N.C.), Richard Blumenthal (D-Conn.), Shelley Moore Capito (R-W.Va.), Mazie Hirono (D-Hawaii) and James Lankford (R-Okla.).
    The bipartisan proposal is supported by the AARP, AIDS Healthcare Foundation, American Pharmacists Association, Biotechnology Innovation Organization, Community Oncology Alliance, National Community Pharmacists Association and National Association of Specialty Pharmacy.
    Pharmacy Benefit Manager (PBM) Transparency Act:
    This bill bans deceptive and unfair pricing schemes, prohibits arbitrary claw backs of payments made to pharmacies, and requires PBMs to report to the FTC on how much money they make through spread pricing and pharmacy fees. The bill falls within the jurisdiction of the Senate Commerce Committee.
    Additional cosponsors are Sens. Joni Ernst (R-Iowa), Peter Welch (D-Vt.), Shelley Moore Capito (R-W.Va.), Jeanne Shaheen (D-N.H.), Roger Marshall (R-Kan.), Martin Heinrich (D-N.M.), Jerry Moran (R-Kan.), Cindy Hyde-Smith (R-Miss.), Thom Tillis (R-N.C.) and Mike Rounds (R-S.D.).
    The bipartisan proposal is supported by the AARP, AIDS Healthcare Foundation, American Pharmacists Association, Association for Clinical Oncology, Association of Mature American Citizens, Autoimmune Association, Biotechnology Innovation Organization, Crohn’s & Colitis Foundation, Community Oncology Alliance, National Community Pharmacists Association and National Association of Specialty Pharmacy.
    “AARP, which advocates for the more than 100 million Americans aged 50 and over, is pleased to support the Prescription Pricing for the People Act of 2025 and Pharmacy Benefit Manager (PBM) Transparency Act of 2025. We value your ongoing bipartisan efforts to lower drug prices for consumers and taxpayers. It is outrageous that Americans pay the highest prices in the world for prescription drugs,” said Bill Sweeney, Senior Vice President, Government Affairs, AARP.
    “APhA supports Senators Grassley’s and Cantwell’s reintroduction of the Pharmacy Benefit Manager Transparency Act, which would go a long way toward addressing PBMs’ anticompetitive business practices putting many independent pharmacies out of business and creating ‘pharmacy deserts’ in rural and underserved communities, where the neighborhood pharmacy may be the only health care provider for miles. We also support the Prescription Pricing for the People Act directing the FTC to report on ways to enforce antitrust and consumer protection laws. APhA stands ready to work with Senators Grassley and Cantwell and the FTC to not only examine PBMs’ anticompetitive business practices but to take the necessary actions to end them,” said the American Pharmacists Association.
    “The Community Oncology Alliance (COA) commends Senators Grassley and Cantwell for once again taking an early lead in introducing pharmacy benefit manager (PBM) legislation in the 119th Congress. The Prescription Pricing for the People Act (S.113 in the 118th Congress) and the Pharmacy Benefit Manager (PBM) Transparency Act (S.127 in the 118th Congress) lit the fuse for additional legislation in both the Senate and the House to stop the top PBMs from harming patients, especially those with cancer. We thank Senators Grassley and Cantwell for their leadership in reintroducing these bills in the 119th Congress. Americans face medication delays and denials, as well as higher costs and waste, at the hands of the top PBMs, especially CVS/Caremark, Cigna/Express Scripts, and United/Optum Rx, which control 80 percent of the prescription drug market. They have to be stopped from harming cancer patients and others with serious diseases. It’s time for Congress to act now!” said Ted Okon, Executive Director, Community Oncology Alliance (COA).
    “Increased transparency into PBM operations is critical to understanding the many ways their underhanded tactics lead to increased costs, delayed access to care, and an unfair marketplace for independent pharmacies – tactics that need swift, significant reforms. The PBMs’ attempt to block every action to increase transparency in the drug delivery system should concern everyone from patients to policymakers. We’re grateful to our allies in Congress like Sens. Grassley and Cantwell for keeping these bills on their agenda and pushing for accountability and change. PBM reform cannot wait,” said B. Douglas Hoey, CEO, National Community Pharmacists Association.
    “IBD patients deserve to understand why PBMs are making the decisions that they do, and whether these decisions are financially motivated or based on science. They should also share in any cost savings achieved by PBMs. The Pharmacy Benefit Manager Transparency Act would make great strides in revealing the true motives and operating practices of PBMs, and in aligning their incentives with increased patient access to medications,” said Erin McKeon, Director, Federal Advocacy, Crohn’s & Colitis Foundation.
    “The Pharmacy Benefit Manager Transparency Act of 2025 would prevent anti-competitive practices and require PBMs to operate with full transparency. This bill ensures that PBMs can no longer manipulate pricing, prioritize profits over patients, or exploit loopholes that drive up costs. AMAC Action is committed to protecting seniors from predatory pricing schemes and ensuring they have access to affordable prescription medications. We commend you both for leading this bipartisan effort and urge Congress to swiftly pass this legislation to bring long-overdue transparency and accountability to the PBM industry,” said Andrew J. Mangione Jr., Senior Vice President, AMAC Action.
    About Pharmacy Benefit Managers
    PBMs were initially formed in the 1960s to process claims and negotiate lower drug prices with drug makers. Now, PBMs administer prescription drug plans for hundreds of millions of Americans.
    Today, three PBMs control nearly 80 percent of the prescription drug market. They serve as middlemen, managing every aspect of the prescription drug benefits process for health insurance companies, self-insured employers, unions and government programs.
    They operate out of the view of regulators and consumers — setting prescription costs, deciding what drugs are covered by insurance plans and how they are dispensed, pocketing unknown sums that might otherwise be passed along as savings to consumers, and undercutting local independent pharmacies.
    This lack of transparency makes it impossible to fully understand if and how PBMs might be manipulating the prescription drug market to increase profits and drive-up drug costs for consumers.
    Background:
    Grassley has long championed efforts to reduce the cost of prescription drugs. Three pieces of legislation authored and coauthored by Grassley have been signed into law to combat anticompetitive practices and stop drug makers from reaping profits at the expense of taxpayers and consumers. Grassley has also led in-depth congressional investigations to expose those responsible for prescription drug price gouging.  
    Other actions include:
    January 2025: Grassley welcomed the FTC’s second interim staff report on PBMs and urged congressional and executive branch action.
    July 2024: Grassley welcomed the FTC’s interim staff report on PBMs and urged congressional and executive branch action.
    January 2024: Grassley sent a letter urging the FTC to complete its investigation into the health care industry’s most powerful prescription drug middlemen.
    November 2023: The Finance Committee adopted a Grassley-led provision to strengthen oversight of CMS and hold PBMs accountable. 
    July 2023: The Finance Committee adopted several Grassley-led PBM accountability provisions. 
    March 2023: The Senate Commerce Committee passed a Grassley-backed bill to hold PBMs accountable for unfair practices driving up costs for consumers.
    February 2023: The Senate Judiciary Committee — which Grassley currently chairs — passed five Grassley-led bills to boost competition in the pharmaceutical industry and improve patients’ access to more affordable prescription drugs.
    October 2022: Grassley led a bipartisan letter urging the FTC to complete its investigation into PBMs to shine light on drug pricing practices.
    January 2021: Grassley and Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) released a two-year bipartisan investigation into insulin price gouging.
    August 2018: Grassley requested the FTC assess pharmaceutical supply chain intermediaries.
    Learn more about Grassley’s persistent efforts to lower prescription drug costs HERE.

    MIL OSI USA News

  • MIL-OSI USA: Duckworth Holds Senate Floor to Protest HHS Nominee Robert F. Kennedy Jr., Underscores How RFK’s Extreme Views Would Endanger the Health of Millions of Middle-Class Americans

    US Senate News:

    Source: United States Senator for Illinois Tammy Duckworth

    February 12, 2025

    [WASHINGTON, D.C.] – Today, U.S. Senator Tammy Duckworth (D-IL) joined Senate Democrats’ protest opposing Robert F. Kennedy Jr.’s nomination to serve as the Director of the Department of Health and Human Services (HHS) under President Trump. In her remarks, Duckworth underscored just how unqualified Kennedy is for the job and how his long-held, well-established extreme views would put programs and services that millions of middle-class Americans rely on—like Medicaid—at risk. Video of Duckworth’s full speech can be found on the Senator’s YouTube, Twitter/X and Facebook.

    Key quotes:

    • “Next month will mark the five-year anniversary of when COVID shut down our nation. In this moment, it is dangerous, reckless and heartless to everyone who lost a loved one in the pandemic to even consider nominating a guy who has stated that, quote, ‘no vaccine is safe and effective.’ And if our HHS Secretary refuses to ensure children are protected against preventable-yet-deadly diseases—like measles, RSV, whooping cough or polio—it will be our kids, not Mr. Kennedy, who pay the price.”
    • “The only reason Kennedy is even up for confirmation is because he, like Elon Musk, decided to throw his dignity to the wind and bow down at Trump’s altar. And because of that, he gets to be yet another rich guy with too few qualifications and too much power somehow now charged with leading our government… So why would any of us ever think that he’d have the courage to stand up to Trump if the President issues an order that actively harms everyday Americans? How could any of us actually believe that Kennedy would fight back against Trump’s worst instincts, when Kennedy has proven time and again that he believes more in sycophancy than science?”
    • “Americans are going be the ones to suffer. Because now, with Kennedy’s confirmation, even programs as popular, effective and vital as Medicaid will be in even greater danger… Medicaid is a lifeline for kids, pregnant women, people in nursing homes and Americans with disabilities. But Republicans don’t seem to care about any of that. It’s obvious that Donald Trump has never stayed up late at night hunched over the kitchen table, with a calculator in one hand and a medical bill in the other, praying to figure out a way to afford his child’s insulin.”
    • “To my colleagues on the other side of the aisle: I am sure many of you have faced health crises of your own. I’m sure many of you have had a parent who’s been sick or a nephew who’s been in a car crash, a spouse who’s needed an emergency C-section or a child who’s relied on an autoimmune injector. Imagine if your loved one hadn’t had care they could rely on in that moment. Then ask yourself how you can sleep soundly tonight if you vote to further the agenda of a couple rich guys who so clearly don’t care about making America healthy—they only care about tipping it even more in favor of the wealthy. They’re not bringing back the good ole days of Reagan. They’re just bringing back the days of dying from the measles. And they’re certainly not making America great again. They’re making America sick again. That’s the Trump-Kennedy promise.”

    Duckworth’s opening remarks as prepared below:

    You know, if you go back exactly 20 years ago today, I could tell you exactly where I was. I was in Walter Reed Medical Center. I was staring at the beige colored walls. And amidst the pain in every inch of my body, I was trying to muster the strength to sit up, or to take a step, or even just to take a breath.

    I spent months and months and months in that room. Hooked up to machines, getting wheeled in and out of surgeries, learning how to live again in my new, post-shootdown world. But despite it all, looking back, I consider every one of those days in that hospital room lucky.

    Because when the worst happened to me—when that RPG exploded in my lap in Iraq and I needed serious, sustained medical attention to survive the hour, the day, the year—I had health care I could rely on.

    The same cannot be said for countless Americans.

    Americans whose health care costs have already been too high, and whose access to care is in even greater danger if this Chamber is foolish enough to confirm Robert F. Kennedy Jr. as our next Secretary of HHS. Put simply, Mr. Kennedy cannot be trusted with the grave, grave responsibility that comes with this job.

    He cannot be trusted with our lives. He is focused on pushing his agenda—regardless of the cost to middle-class Americans. And if this man is confirmed, more Americans will die preventable deaths because of his policies.

    Next month will mark the five-year anniversary of when COVID shut down our nation. In this moment, it is dangerous, reckless and heartless to everyone who lost a loved one in the pandemic to even consider nominating a guy who has stated that, quote, “no vaccine is safe and effective.”

    And if our HHS Secretary refuses to ensure children are protected against preventable-yet-deadly diseases—like measles, RSV, whooping cough or polio—it will be our kids, not Mr. Kennedy, who pay the price.

    I’ve gotten letter after letter from my constituents, begging me to try to reason with my colleagues, to do whatever I can to prevent a man so ignorant of all things science and medicine from holding a position of such power over our child’s next breath.

    One pediatrician from Illinois wrote to me: I will always remember the 9-month-old infant with whooping cough who could not be saved despite every high-tech ventilator and medication we had available.” Another said: “I recall a father screaming and punching a hole in the wall when his 4-year-old son died of chicken pox.” The stories, the letters, the avoidable tragedies go on and on. Imagine how much worse the heartbreak will become under a guy who acts like the term “vaccine” is a swear word.

    Look, the only reason Kennedy is even up for confirmation is because he, like Elon Musk, decided to throw his dignity to the wind and bow down at Trump’s altar.

    And because of that, he gets to be yet another rich guy with too few qualifications and too much power, somehow now charged with leading our government.

    Trump is running this country like the mob: Kiss his ring, pledge your unyielding loyalty, get made—it’s just this time, you get made into a Cabinet Secretary. Well, Kennedy has given Trump his fealty.  So why would any of us ever think that he’d have the courage to stand up to Trump if the President issues an order that actively harms everyday Americans?  How could any of us actually believe that Kennedy would fight back against Trump’s worst instincts, when Kennedy has proven time and again that he believes more in sycophancy than science?

    Now, Americans are going be the ones to suffer. Because now, with Kennedy’s confirmation, even programs as popular, effective and vital as Medicaid will be in even greater danger. Republicans told us in Project 2025 that they would come for Medicaid—and this is the rare case when the GOP has actually kept its word, putting at risk the roughly 80 million Americans who rely on it. Americans in red states and blue, in big cities and small towns—folks who may have never heard of RFK Jr., but who will certainly feel the effect when he rips away the care their family so desperately needs.

    Medicaid is a lifeline for kids, for pregnant women, for people in nursing homes, for Americans with disabilities. But Republican’s don’t seem to care about any of that. It’s obvious that Donald Trump has never stayed up late at night hunched over the kitchen table, with a calculator in one hand and a medical bill in the other, praying to figure out a way to afford his child’s insulin.

    No. Of course not.

    With every passing day, it becomes clearer and clearer that Republicans care more about tax breaks for the billionaires they pal around with on the golf course than prescriptions for the middle-class folks who actually work at Mar-a-Lago.

    And while that teacher in Peoria lays awake at night, trying to work out how she can afford her father’s home care now that he can no longer get those services through Medicaid… While that new mom in Chicago who’s just learned she has stage 3 cancer is trying to find a second job so she can afford both diapers for her newborn and her own chemotherapy… Donald Trump and Elon Musk will be too busy lining their already-full pockets to care.

    To my colleagues on the other side of the aisle: I am sure many of you have faced health crises of your own. I’m sure many of you have had a parent who’s been sick or a nephew who’s been in a car crash… a spouse who’s needed an emergency C-section or a child who’s relied on an autoimmune injector. Imagine if your loved one hadn’t had care they could rely on in that moment.

    Then ask yourself how you can sleep soundly tonight if you vote to further the agenda of a couple rich guys who so clearly don’t care about making America healthy—they only care about tipping it even more in favor of the wealthy. They’re not bringing back the good ole days of Reagan. They’re just bringing back the days of dying from the measles.

    And they’re certainly not making America great again. They’re making America sick again. That’s the Trump-Kennedy promise.

    I care about my constituents’ ability to afford their prescription meds. Their ability to get the vaccines that’ll keep them alive through the next pandemic. Their ability to survive those worst-case-scenario health moments without going broke in the process.

    So for all those reasons and a thousand more, I will be voting no on Robert F. Kennedy Jr’s nomination. If my Republican colleagues care about any one of those things, too, then they will have no choice but to do the same. Thank you.

    -30-

    MIL OSI USA News

  • MIL-OSI USA: In Forceful Senate Floor Speech, Murray Lays Out Real Dangers of Confirming RFK Jr., Calls on Colleagues to “Show Some Courage,” Reject Anti-Vaccine Conspiracy Theorist as Top Health Official

    US Senate News:

    Source: United States Senator for Washington State Patty Murray
    Murray: “If you think RFK Jr. will change who he is, you are lying to yourself… If you do not draw a line somewhere, you will cross every line you could ever imagine. You will be pushed further and further into accepting things you never thought you would—things you never thought you could.”
    ICYMI: In Senate Hearing, RFK Jr. Refuses to Say HPV Vaccine is Safe to Sen. Patty Murray, Pressed on Credible Accusation of Sexual Assault
    Murray, a longtime congressional leader on health care who has led hearings on addressing vaccine hesitancy, has been a leading vocal opponent of RFK Jr.’s nomination—speaking out on the Senate floor, holding events, raising the alarm after meeting with him
    *** VIDEO of Senator Murray’s floor speech HERE***
    Washington, D.C. — Today, U.S. Senator Patty Murray (D-WA), a senior member and former Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, took to the Senate floor to warn of the very real dangers that lie ahead if Republicans insist on confirming RFK Jr. as Secretary of the U.S. Department of Health and Human Services (HHS) and urge her colleagues to “show some courage… show some conscience” and vote against this nomination.
    Murray laid out the many ways RFK Jr. could undermine vaccines as HHS Secretary—as well as so much else that’s at stake with his confirmation. Murray pointed out that, if confirmed, there will be nothing stopping RFK Jr. from firing the CDC’s entire vaccine advisory committee—responsible for making recommendations about vaccines and indirectly determines which vaccines must be covered by insurance—and replacing them all with vaccine skeptics. RFK Jr. will also oversee FDA, another agency he has repeatedly tried to discredit and attack—and where he has said he plans to fire hundreds of scientists on Day One.
    “My colleagues should know better. They do know better,” said Murray on the Senate floor. “But they are looking the other way. They are choosing to pretend like it is in any way believable that RFK Jr. won’t use his new power to do exactly the thing he has been trying to do for decades—undermine vaccines.”
    Murray spoke about how RFK Jr. will also have jurisdiction over NIH, where he could redirect funds away from promising cures, or make good on his plan to fire hundreds of researchers and pause infectious disease research. Pointing to Donald Trump and Elon Musk’s’ recent attacks on NIH biomedical research funding, Murray said: “At a time when lifesaving research like this is already under attack from the President and the richest man in the world, no one who truly values medical research should vote to install one of the biggest attackers of medical science as the Secretary of Health and Human Services.”
    Murray also spoke about health insurance—another huge responsibility for HHS. “Last time Trump was in office, we saw millions of people lose their health coverage,” Murray said. “The uninsured rate went up after years of hard-won progress, and we all know he still wants to rip up the Affordable Care Act—driving up costs and kicking people off their coverage. And there’s no reason to think Mr. Kennedy will stand up to that effort. Indeed, there is no reason to think he has the experience and understanding of the system to do so. During his committee hearings, RFK Jr. confused Medicare and Medicaid—basic stuff—and failed to describe the components of Medicare.”
    Murray also hammered how RFK Jr. poses an enormous risk to reproductive health care in America—pointing out that not only did RFK Jr. confess to having no real understanding of the Department’s role in enforcing Americans’ right to emergency care, but he showed he will be totally open to Republicans’ efforts to rip away access to medication abortion nationwide.
    Also noting the danger of putting RFK Jr. in charge of pandemic threats, Murray emphasized that “We cannot take this man at his word—something he has changed and gone back and forth on time and again. But we can take him at his record—which is that he has consistently undermined vaccine confidence and even profited from it.”
    “I cannot tell my colleagues enough: this isn’t a game, this is not a political role without consequence, the Health Secretary has real power over whether Americans can get basic information and care that impacts whether they live or die,” Murray continued.
    “So if my colleagues are feeling the pressure from President Trump or if they are feeling the weight of the richest man in the world on their backs, I would warn them: this will certainly not be the last test we face here in the Senate… If you do not draw a line somewhere, you will cross every line you could ever imagine. You will be pushed further and further into accepting things you never thought you would—things you never thought you could.
    “I think most of my colleagues know what is really at stake here. I think most of my colleagues know what sort of man RFK Jr. is and what sort of damage he could do if confirmed. There are political realities, we all get that—but there is also right and wrong… So, I urge all my colleagues to show some courage. I urge them to show some conscience. I urge them to join me in voting NO on RFK Jr.’s nomination,” Murray concluded.
    When President-elect Donald J. Trump first announced his intention to select Robert F. Kennedy Jr. as Secretary of HHS, Murray immediately and forcefully condemned the move—and she has consistently spoken out and laid out for her colleagues the case against his nomination since, including in a lengthy Senate floor speech earlier this month—VIDEO HERE. Murray met with RFK Jr. on January 15th and released a statement afterward reiterating her opposition to his nomination and urging her colleagues, “to be honest with themselves about the stakes of putting one of the anti-vaccine movement’s loudest, proudest champions in charge of HHS and join me in opposing RFK Jr.’s nomination.” In December, Murray held a roundtable discussion at UW Medicine on the importance of scientific research and vaccines—especially for children—and spoke about how having RFK Jr. lead HHS would threaten Americans’ health and safety. At the hearing on his nomination before the Senate HELP Committee, Senator Murray pressed RFK Jr. to acknowledge that the HPV vaccine was safe and effective—he would not—and respond to credible accusations of sexual assault.
    As a longtime appropriator and former Chair of the Senate HELP Committee, Murray has long fought to boost biomedical research, strengthen public health infrastructure, and make health care more affordable and accessible. Over her years as a senior member of the Appropriations Committee, she has secured billions of dollars in increases for biomedical research at the National Institutes of Health, and during her time as Chair of the HELP Committee she established the new ARPA-H research agency as part of her PREVENT Pandemics Act to advance some of the most cutting-edge research in the field. As Chair of the HELP Committee, Murray was also instrumental in crafting the American Rescue Plan Act, including its landmark investments in public health and health care. Senator Murray was also the lead Democratic negotiator of the bipartisan 21st Century Cures Act, which delivered a major federal investment to boost NIH research, among many other investments. Murray is also the lead sponsor of the Public Health Infrastructure Saves Lives Act (PHISLA), legislation to establish $4.5 billion in dedicated, annual funding for a grant program to build up and maintain the nation’s public health system across the board. 
    In 2019, Senator Murray co-led a bipartisan hearing in the HELP Committee on vaccine hesitancy and spoke about the importance of addressing vaccine skepticism and getting people the facts they need to keep their families and communities safe and healthy. Ahead of the hearing, as multiple states were facing measles outbreaks in under-vaccinated areas, Murray sent a bipartisan letter with former HELP Committee Chair Lamar Alexander (R-TN) pressing the Centers for Disease Control and Prevention (CDC) Director and HHS Assistant Secretary for Health on their efforts to promote vaccination and vaccine confidence.
    Senator Murray’s full remarks on the Senate floor, as delivered are below and HERE:
    “Mr. President, the American people are watching now with alarm—because the vast majority of people know: vaccines are safe, they’re effective, they are lifesaving.
    But we are now on the verge of confirming, as our nation’s highest health official, a man who has spent considerable time, money, and effort undermining that basic fact.
    “A man who has abused his platform by refusing to acknowledge the well-established science that shows that vaccines arenot linked to autism. Fear about that point—fueled by RFK Jr. and others peddling misinformation—is a leading reason that parents do not get their kids vaccinated against preventable, dangerous diseases.
    “That’s why elevating a man like RFK Jr. to lead HHS would be so dangerous. Just giving him any platform to spread vaccine doubt is dangerous. But to give him one of the biggest megaphones in the world? It is truly shameful that we even are debating this.
    “My colleagues should know better. They actually do know better. They are looking the other way. They are choosing to pretend like it is in any way believable that RFK Jr. won’t use his new power to do exactly the thing he has been trying to do for decades—undermine vaccines.
    “Never mind the fact that CDC has already modified webpages with information about vaccines and other vital public health information—which a federal judge has now ordered the Trump Administration to restore.
    “Never mind that the Trump administration is also, reportedly, planning widespread and significant layoffs—layoffs—at CDC and across HHS.
    “This is how RFK Jr. substitutes his own beliefs for science. So, when the vaccine conspiracies start swirling—and RFK Jr. turns HHS into ground zero for misinformation—‘I had no idea’ is not going to be an excuse for confirming him.
    “Because at the HELP Committee hearing, the Chair pressed him repeatedly about the debunked claim that vaccines cause autism. And when RFK Jr. said he needed to ‘see the evidence,’ he was shown the evidence. But, to no one’s surprise, he did not keep his word, admit he’d been wrong, and spread the good news that vaccines do not cause autism.
    “He has had two weeks since that hearing to look at the same settled science as everyone else—crickets. But he won’t hesitate to quote the latest anti-vax conspiracy. He is totally up to speed on that front.
    “Are my colleagues really buying this guy will take an impartial look at the science?
    “If you think RFK Jr. will change who he is, you are lying to yourself. He has given no evidence to suggest that—and all the evidence in the world to the contrary.
    “Given his long, and growing track record, we cannot just pretend if RFK Jr. finally gets power to undermine vaccines—a cause that he has dedicated a considerable amount of time and effort to—that he’ll just give it up. That is not believable.
    “And I know I’ve been talking a lot about vaccines—because it is so obviously alarming—but the responsibility he would have goes far beyond that.
    “So, let’s break some of this down—both the ways he could undermine vaccines as HHS Secretary, and the other responsibilities that would be at stake.
    “To start with, the CDC is under HHS. That means that the Secretary directly appoints people to CDC’s vaccine advisory board. That board is responsible for making recommendations about vaccines—and it is those recommendations that determine whether or not certain vaccines have to be covered by insurance.
    “So, simply put: changing those recommendations will change what vaccines millions of Americans, including kids, will be able to get from their health care provider.
    “If he is confirmed, there would be nothing stopping RFK Jr. from firing the entire board and replacing them all with vaccine skeptics.
    “After all, he has said many times, and in many ways, he thinks CDC is corrupt and bought by pharma—as usual, by the way, without any evidence.
    “RFK. Jr. would also oversee the Food and Drug Administration; that is another agency he has repeatedly tried to discredit and attack—where he says he plans to fire—fire!—hundreds of scientists on Day One. And an agency that plays the crucial role of making sure our drugs and our treatments—including vaccines—are safe and effective.
    “Not only would Mr. Kennedy have a key perch from which he could undermine vaccines on a scale like never seen before, he could also use his platform to peddle quack treatments with no basis in science.
    “RFK Jr. would also have jurisdiction over NIH. That alone means influence over billions of dollars in medical research—research that is responsible for a significant portion of our economy, and more importantly, research that patients are desperately hoping will help them find cures. 
    “But RFK Jr. could redirect those funds to promote his favorite pet conspiracies instead of promising cures.
    “Or he could make good on his plan to fire hundreds of researchers and pause infectious disease research—for eight years. It should go without saying: viruses aren’t going to take a break.
    “And here’s the thing—the attacks on medical research are now already happening under Trump. From his day one Executive Orders, President Trump has already been threatening medical research.
    “Suddenly, all of our grants are at risk because they are looking at addressing ‘barriers to care’ or understanding why Black and Native American women have higher maternal death rates.
    “And now—President Trump also is trying to illegally, arbitrarily, and suddenly change NIH guidelines to set an unrealistically low cap on indirect cost rates. That would mean researchers are laid off, studies canceled—including lifesaving clinical trials—and kids are not able to get the treatment they need.
    “All because President Trump and Elon Musk don’t seem to understand how we actually fund important research, and couldn’t even be bothered to find out before taking an axe to medical research labs.
    “At a time when lifesaving research like this is already under attack from the President, and the richest man in the world, no one who truly values medical research should vote to install one of the biggest attackers of medical science as the Secretary of Health and Human Services.
    “And, M. President, insurance is another huge portfolio for HHS. Last time Trump was in office, we saw millions of people lose their health care coverage. The uninsured rate went up after years of hard-won progress, and we all know he still wants to rip up the Affordable Care Act—which will drive up costs and kick people off their coverage.
    “There’s no reason to think Mr. Kennedy will stand up to that effort. Indeed, there is no reason to think he has the experience and understanding of the system to actually do so.
    “During his committee hearings, RFK Jr. confused Medicare and Medicaid—this is basic stuff! He failed to describe the components of Medicare. 
    “And yes, Mr. President, I also absolutely have to talk about abortion care. This is of grave importance—especially right now.
    “In his hearings, not only did RFK Jr. confess to having no real understanding of EMTALA—that is a law which requires patients have access to lifesaving emergency care including, in some cases, abortion care—he also showed that he will be totally open to Republicans’ fact-free efforts to rip away access to medication abortion.
    “Like so many other issues that RFK Jr. is simply wrong about, the science on that has been settled for many years now.
    “Mr. Kennedy made clear though, he is very open to revisiting access to the abortion pill, based on a Republican argument against the science that basically boils down to: ‘Nuh uh, nuh uh!’
    “Putting up barriers to accessing the abortion pill—or ripping it off the market completely, as Republicans have made very clear they want to do—would be absolutely devastating.
    “And let’s not forget about pandemic threats. The lies that RFK Jr. spread during the last pandemic already make clear he is not the man to do this job. But if that weren’t enough, when there was a pandemic threat response planning session for this new Administration—he skipped it! He didn’t go! It would almost be comical if this wasn’t so serious.
    “Mr. President, everywhere you look, everything about this nominee is so concerning.
    “We cannot take this man at his word—something he has changed and gone back and forth on time and time again. But we can take him on his record—which is that he has consistently undermined vaccine confidence and, by the way, note: he even profited from that.
    “And we can take the threat of what he might do seriously, especially given the alarming things that are already happening.
    “If RFK Jr. gives you his word of honor, that he won’t freeze research—well guess what? We are already seeing the Trump Administration totally upend medical research. Thanks to the Trump funding freeze, NIH hasn’t issued any grant awards in weeks!
    “If RFK Jr. swears that he is not going to take down information about vaccines, that he is not going to silence experts, well don’t look now—but the Trump Administration has already taken down or changed CDC pages about vaccines. They have already silenced public health experts.
    “If RFK Jr. pinky promises you that he won’t undermine medical science or studies, and he won’t ignore global health threats, well, you might want to sit down for this—but President Trump has completely demolished our global health aid work. He has already completely demolished it.
    “The fallout is utterly heart wrenching. Already we know of a woman who died—because the USAID-supported hospital she went to for oxygen was forced to discharge her because they got a ‘stop-work’ order from the Trump administration.
    “It is not clear if she was the first death caused by Trump’s complete freeze, but there is no question, she will not be the last.
    “And Mr. President—let me make a really important point here: it is not just people across the world who will be affected by this.
    “There was a study being done on a new HIV treatment with thousands of volunteers, a study being done already having a thousand volunteers doing the treatment. But now, without their regular injections, which are cut off because of Trump’s move, there is going to be too little of the drug in their system to protect those people from HIV—but enough of the drug that if they contract HIV, it could mutate to become drug resistant.
    “So, for all the absolutely unhinged conspiracies we have heard about medical research from RFK Jr. and the like, where is the concern for this actual risk, in this actual study, happening right now all because President Trump cut off foreign assistance?
    “RFK Jr. has been silent about that risk, silent about how wrong that is—and so, even as he is making these empty promises on one hand to some of our colleagues, he is already standing by as President Trump breaks them on the other hand.
    “Oh, and here’s one more—if RFK Jr. says he is going to consult you on health care personnel, please do not be fooled.
    “Look, I don’t know why my colleagues need me to tell them this—I like to think we have some pretty smart people around here—but this vote, RFK Jr.’s own nomination, this is your consultation on health care personnel. Not some made up promise for later. This is the point you have the most power.
    “Whatever he might say, you don’t get to choose who RFK Jr. will appoint to this or that—heck, he doesn’t get to choose who President Trump appoints. 
    “The decision you get to make, all of us on this floor get to make, is the decision on this floor before us right now. You get to choose who you vote to confirm. And you will have to live with that decision.
    “And, if you ignore the warning signs, and confirm RFK Jr.—then, when the wheels fall off the wagon, you may try to tell yourself you were lied to, but you knew who you were dealing with. You knew who you were dealing with. You knew what he has said before, and what he has refused to say.
    “You had all the knowledge you needed to do the right thing.
    “I cannot tell my colleagues enough: this is not a game, this is not a political role without consequence. The Health Secretary has real power over whether Americans can get basic information and care that impacts whether they live or die.
    “As I have tried to drive home throughout this process—vaccines save lives. That is not a question. It is not a slogan. It is a fact.
    “If, when parents look to you, worried about their newborn, wanting to do what is best for their baby, and trusting your advice as a public health leader—if you cannot tell them the same truth that centuries of science and experience tells us, which is that vaccines are safe, effective, and lifesaving, then you have absolutely no business leading the Department of Health and Human Services. None. 
    “And so, just as I did at the hearing, I want to warn all of my colleagues: by merely voting to confirm Mr. Kennedy, we would be telling our constituents he is worth listening to on vaccines. That alone will get people killed—before he even lifts a finger.
    “Because he does not even need the levers of power to get people killed—all he needs is a megaphone.
    “To affirm his views by voting to confirm him as our highest health official—let’s not mince words about what that will mean.
    “When babies die from whooping cough because parents weren’t sure the vaccine was safe—will you be able to look them in the eye? When the flu sweeps our nursing homes, when measles sweeps through our communities—will it be worth it?
    “Mr. President, I will end on this—I’m sure there are plenty of members who know perfectly well just how dangerous it would be to confirm RFK Jr. They don’t need to hear it from me—in fact, some of them may even know the danger better than I do.
    “But here’s what I do know: conscience is a muscle. Courage is a muscle. The less you use them, the more they fade away.
    “So if my colleagues are feeling the pressure from President Trump or if they are feeling the weight of the richest man in the world on their backs on this vote, I would warn them: this will certainly not be the last test we face here in the Senate.
    “Giving into pressure now won’t make it go away. It won’t soften the pressure you face later, and it will not strengthen your resolve when the stakes are higher. It will just show: pressure works.
    “If you do not draw a line somewhere, you will cross every line you could ever imagine. You will be pushed further and further into accepting things you never thought you would—things you thought you never could.
    “I think most of my colleagues know what is really at stake here. I think most of my colleagues knowwhat sort of man RFK Jr. is, and what sort of damage he could do if confirmed.
    “There are political realities, we all get that—but there is also right and wrong. There is also fact and fiction.
    “There is people staying healthy, and people dying pointlessly—kids dying pointlessly—from diseases that we can prevent, because they thought Congress took its job vetting our health secretary seriously.
    “So, M. President, I urge all my colleagues to show some courage. I urge them to show some conscience. I urge them to vote NO on RFK Jr.’s nomination.”

    MIL OSI USA News

  • MIL-OSI United Kingdom: expert reaction to study looking at hormonal contraceptives and stroke and heart attack risk

    Source: United Kingdom – Executive Government & Departments

    A study published in the BMJ looks at hormonal contraceptives and the risk of heart attacks and strokes.

    Dr Sonya Babu-Narayan, Clinical Director at the British Heart Foundation and consultant cardiologist, said:

    “You shouldn’t be overly alarmed by these findings if you are using or considering starting hormonal contraception.  The additional risk of heart attack and stroke is very low for the vast majority – it’s equivalent to one extra heart attack for every 10,000 women using hormonal contraception for a year.  And pregnancy itself also increases your risk of developing blood clots, stroke and heart attack.

    “When considering hormonal contraception options, you will be able to discuss the risks and benefits with your GP so that you can make an informed decision about what is best for you.  This could include discussion and management of your existing cardiovascular risk factors like high blood pressure, diabetes, smoking, or if you are living with obesity.

    “The study lends weight to previous evidence of an association between hormonal contraception use and a small increase in the number of heart attacks and strokes.  The researchers made use of a wealth of long-term electronic healthcare information from over 2 million people in Denmark – this scale and breadth makes the findings more reliable and complete than previous studies and enables study of even rare complications like these.

    “However, the study is observational so it can’t prove cause and effect, and there may be other factors at play driving the links seen that aren’t sufficiently accounted for.

    “This latest study supports the current practice of recommending the option of a progestin intrauterine device – the hormonal coil – for those already living with high cardiovascular risk, as this wasn’t linked to more heart attacks and strokes.”

    Dr Becky Mawson, NIHR Clinical Lecturer in Primary Care, and GP with special interest in sexual and reproductive health, University of Sheffield, said:

    “Please do not stop using contraception based on this study!  The risk of stroke and heart attack in pregnancy and postnatal period is significantly higher than the risks reported in this study for contraceptives.  For those using contraceptives for treatment of health conditions, the slightly increased risk needs to be balanced with the benefit in quality of life for those suffering debilitating gynaecological and hormonal conditions.

    “Saying that, if you have other risk factors for strokes and heart disease, then it is worth discussing with your healthcare team to look at the safest options like the hormonal coil.  This observational study looks at relationships in data, not causes.  It adds to previous studies within the same database looking at increased blood clot risk.

    “While it remains true as it has done for years that we need to find better, risk-free alternatives to prevent pregnancy, in my view this study hasn’t changed that and should not cause alarm but does add to growing knowledge in this area.”

    Dr Clare Arnott, Conjoint Associate Professor, Cardiologist and Head of Cardiovascular Program, The George Institute for Global Health, and UNSW Sydney, said:

    “This is an interesting, timely and important study.  It is wonderful to see sex-specific cardiovascular risk factors given appropriate attention in medical research.

    “The study identified twice the risk of stroke and heart attack in those exposed to the combined oral contraceptive pill (and around 1.5x the risk for progestin only formulations).  Interestingly, while risk was also increased for the combined vaginal ring and patch (with relative risks higher with these preparations), no increased risk was observed for the progestin-only IUD.  Also of note, and clinical relevance, duration of use did not appear to impact risk.

    “While these relative risks are important, particularly at a public health/population level, it should be noted that absolute risk remains low in this patient population of young women.  It is also important to note that this study excluded women with a history of arterial thrombosis – a high risk group, and thus these results cannot be extrapolated to that population.

    “The study is strengthened by a large cohort size, which is nationally representative, long patient follow up period, and is adequately powered with respect to the number of events recorded.  Of course, as the authors rightly acknowledge, this is observational research, and correlation is not the same as causation.

    “Nonetheless, it is valuable information that should be routinely communicated to women to allow them, in conjunction with their healthcare provider, to make informed decisions about their health.  These data are also very important at a public health/ population level given the >200 million women worldwide using hormonal contraception, and thus public health clinicians and policy makers should take note.”

    Prof Angela Clerk, Professor of Biomedical Science, University of Reading, said:

    “The study appears to be comprehensive and rigorous, representing the whole of the Danish population.  There should be some caution in extrapolating to other populations with different ethnicities, since genetic background and cultural variation could affect cardiovascular risk, and some ethnicities not fully covered by the Danish population could have greater vulnerability.

    “This is clearly an important study but, while the focus is on the potential negative effects of contraception on cardiovascular risk, it is also clear that any increase in risk is actually very small.  This emphasises the overall safety of the drugs, particularly when balanced against the negative effects of unwanted pregnancies resulting from a lack of contraception.  Yes, there should be informed choice of the type of contraception, but perhaps lifestyle choices need to take greater precedence.  Though I am past that stage, this study would not stop me from using any of these forms of contraception over not using one and facing an unplanned pregnancy.”

    Dr Channa Jayasena, Consultant in Reproductive Endocrinology, Imperial College London, said:

    “Contraceptive medication is a vital healthcare option, which offers lower chances of accidental pregnancy compared with barrier contraceptive methods.  Contraceptives work by using high doses of female hormones like oestrogen and / or progesterone to temporarily ‘switch off’ the ovaries and womb.  Oestrogen is a ‘sticky’ hormone because it makes blood more likely to clot.  It is well-known that The Pill increases blood clot risk.  Increased blood clot risk increases risks of related problems like stroke and heart attack.  The current study helps to define the risks of different types of contraceptive medication.

    “The study is well designed because looks at health records from 2 million women of reproductive age living in Denmark.  The authors were careful to adjust for factors which might have affected the results.  The findings confirm that The Pill is associated with increased risks of stroke and heart attack.  Observational studies like this one cannot conclude that the Pill has caused stroke and heart attack; but our prior knowledge of how the pill works makes this likely.

    “My biggest criticism is the way that the results are presented.  Only 3 per 1000 women were affected by a stroke or heart attack; the risk among those on the pill was about 6-10 per 1000.  The absolute risk of having a stroke or heart attack on The Pill is still very low.

    “Women should take away the importance of smoking cessation, healthy eating, and exercise to minimise the (small) increased risk of stroke or heart attack associated with being on the pill.  Women who have high risks of stroke or heart attack that cannot be reduced should strongly consider a hormonal coil, because of its lack of associated increased stroke or heart attack risk.”

    ‘Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study’ by Harman Yonis et al. was published in the BMJ at 23:30 UK time on Wednesday 12 February 2025.

    DOI: 10.1136/bmj-2024-082801

    Declared interests

    Dr Sonya Babu-Narayan: “No conflicts of interests to declare.”

    Dr Becky Mawson: “Current project with South Yorkshire Digital Health Hub – The Hormone Effect – developing an app to collect data on side effects of contraception.

    Research lead (unpaid and no financial benefits) – The Lowdown Women’s Health Platform.”

    Dr Clare Arnott: “None to declare.”

    Prof Angela Clerk: “I no conflict of interest under any of the categories below with respect to industry funding.  I have no conflict of interest with any of my own research under these categories either.  I am a woman, however.”

    Dr Channa Jayasena: “No conflicts to declare.”

    MIL OSI United Kingdom

  • MIL-Evening Report: Tiny splendid peacock spiders have the fastest known jump among their kin – new study

    Source: The Conversation (Au and NZ) – By Ajay Narendra, Associate Professor of Insect Neuroethology, Macquarie University

    Pranav Joshi

    Jumping spiders – one of the largest spider families – get their name from the extraordinary jumps they make to hunt prey, to navigate and also to evade predators.

    Male jumping spiders also jump to escape from cannibalistic females and competing males. So they are under tremendous pressure to jump efficiently and rapidly.

    We studied the jumping abilities of miniature male and female Australian peacock spiders. We found that the males – incredibly light creatures, weighing just 2 milligrams – have the highest acceleration among any known jumping spider.

    Our study is the first to explore and identify differences in how male and female jumping spiders undertake their impressive jumps. It’s now published in the Journal of Experimental Biology.

    A male Australian splendid peacock spider.
    Pranav Joshi

    Unique hydraulics

    Jumping is an energetically “expensive” movement strategy. To perform it, animals have to launch themselves from a surface by coordinating the movement of numerous body parts.

    Some invertebrates, like ants, jump with the help of their muscles. Others, like fleas, use energy stored in internal structures that are rapidly released to trigger a leap.

    Jumping spiders are different – they use a unique semi-hydraulic system. They don’t have muscles to extend their legs and power the jumps. Instead, they extend their legs by increasing the pressure of the haemolymph (fluid analogous to blood in invertebrates) in their legs, which triggers the jump.

    Peacock spiders are well known for the elaborate courtship display males carry out to court females. It has captured the attention of biologists and non-scientific audiences alike. The display includes extending and waving their third pair of legs and opening the colourful flap-like extensions on the abdomen.

    The quantitative description of jumping movements, known as jump kinematics, has only been conducted for four of the 6,000+ jumping spider species known worldwide. On top of this, scientists have never investigated differences in jump dynamics in male and female spiders.

    Because male and female peacock spiders differ strongly in size from each other, they present a unique opportunity to identify sex-specific differences in jump kinematics.

    Spiders on campus

    We studied the Australian splendid peacock spider (Maratus splendens) found both on the Macquarie University campus in Sydney and in the surrounding area.

    The females weighed more than twice as much as males, and the heaviest female was 6.6 times heavier than the lightest male. We scanned male and female specimens using micro-computed tomography and carried out a 3D reconstruction to determine the centre of mass of each sex.

    Micro CT reconstruction of the male of the Australian splendid peacock spider with centre of mass highlighted by a circle.
    Ajay Narendra

    We then filmed the jumps of male and female spiders using a high-speed camera, and tracked the animals’ centre of mass during each jump. From this, we measured a suite of kinematic measures, including jump take-off angle, acceleration, and g-force.

    We found that these lighter male peacock spiders have a distinct jump choreography and kinematics compared to the heavier females.

    High, fast and steep

    We discovered that the splendid peacock spiders accelerated at 127.8 m/s² – more than twice as fast as the previous highest known acceleration in jumping spiders.

    This rapid acceleration may have evolved to escape from predators or to track and capture fast-moving prey in their natural environments.

    Though the lighter males accelerated faster, after controlling for body mass we found that acceleration in males was slower compared to females. Males and females experienced accelerations equivalent to 13.03 times and 12.5 times the force of gravity, respectively.

    Interestingly, the jumps of males were at a steeper angle than those of females, which is likely an adaptation to rapidly escape from females and other males.

    A question that remained was which of the four pairs of legs powered this rapid jump. To figure this out, we tracked multiple joints on all of the spiders’ legs throughout the jump.

    We found that the joint on the third pair of legs had an extremely acute angle before jumping, and rapidly changed to something like a straight angle after attaining maximum acceleration. Our results show that it’s the third pair of legs that propels the splendid peacock spider into its impressive jumps.

    Ajay Narendra receives funding from Australian Research Council.

    ref. Tiny splendid peacock spiders have the fastest known jump among their kin – new study – https://theconversation.com/tiny-splendid-peacock-spiders-have-the-fastest-known-jump-among-their-kin-new-study-247241

    MIL OSI AnalysisEveningReport.nz

  • MIL-OSI New Zealand: Science reforms: Save Science Coalition releases latest toll of science roles in wake of further cuts at Callaghan Innovation

    Source: Save Science

    Over 200 science roles have been cut from the sector since July last year, bringing the total number of roles lost in the government science sector to approximately 570. That is despite the Government trumpeting science as a key to economic growth.
    New figures released by the Save Science Coalition, a group of 30 scientific societies and unions, include an additional proposed 63 roles to be disestablished at Callaghan Innovation as the latest casualties of Government cuts. Staff at Callaghan Innovation were made aware of the proposal on Wednesday.
    “The latest cuts at Callaghan Innovation are a direct result of Government decisions to remove the majority of the organisation’s funding by 30 June this year,” explained Dr Lucy Stewart, spokesperson for the Save Science Coalition.
    “This isn’t stopping – we are expecting hundreds of additional jobs to be lost. We are aware of continuing restructuring occurring at Callaghan Innovation, AgResearch and Manaaki Whenua. This is on top of the Government’s proposed restructure of the science sector, which may result in yet further job losses unless the Government makes a clear plan to retain staff through this process.”
    “The Science System Advisory Group report highlighted that retention of the skilled workforce in this sector was of utmost importance. So far, it is difficult to see how the Government is upholding this principle when we are seeing job cuts continue even after the publication of the much-awaited report.”
    The Save Science Coalition also emphasised that funding the sector is critically important.
    “The Science System Advisory Group announcements included no additional funding for the sector, either to fund the reform programme or the ongoing science. While the reforms may help reduce unproductive competition between agencies, which is a positive thing, the benefits of the changes can only fully be realised if there is appropriate funding made available,” explained Stewart.
    “Merging and rebranding institutions costs money, but according to Cabinet papers the proposed changes are to be funded out of existing allocations. Furthermore, there is no commitment to retaining current scientific expertise, at the same time as the Government talks about wanting to attract new talent to our country. We know many researchers have already been forced to relocate offshore.”
    “The Cabinet papers noted that Aotearoa New Zealand receives a return of $3.50 for each dollar invested in science, innovation and technology. For science to be the solution to New Zealand’s economy, as the Prime Minister has so keenly told us, then he needs to front up and invest in it.”
    The Save Science Coalition has written to Science Minister Dr Shane Reti to discuss these matters.
    The Save Science Coalition was set up in May 2024 and completed a report documenting the cuts to science funding and staffing which was released in July 2024. The group has now released an update to the report, detailing additional cuts made between July 2024 and February 2025. The Coalition has also published its collective response to the reforms announced in January 2025.
    The Save Science Coalition’s goals are:
    – to oppose cuts to science funding and science staff across government institutions
    – to highlight and catalogue what is being lost through the current cuts
    – to defend support for world-leading indigenous research including mātauranga Māori
    – to make the case for a foundation of support for public science and re-committing to a target of 2% of GDP to be invested in research and development in Aotearoa New Zealand.
    Current Save Science Coalition member organisations are:

    MIL OSI New Zealand News

  • MIL-OSI: Ponce De Leon Foundation Grant Awarded in the Amount of $610,000 to Nonprofits

    Source: GlobeNewswire (MIL-OSI)

    BRONX, N.Y., Feb. 12, 2025 (GLOBE NEWSWIRE) — The Board of Directors of the Ponce De Leon Foundation is pleased to announce it has awarded $610,000 to nonprofits that are making a difference in our communities. Since its inception in 2017, the Foundation has provided over $2.4 million in grants.

    Madeline V. Marquez, Executive Director of the Ponce De Leon Foundation, stated, “Year after year our grant applications increase, and it is evident the immense needs in our communities. We pride ourselves in ensuring all our focus areas are recognized and that we spread our funds equitably as we continue to support and strengthen the impact to our organizations.”

    Carlos P. Naudon, President and Director of the Ponce De Leon Foundation, stated, “The mission on corporate social responsibility remains, we live it, breathe it and stay true to it. Once again overjoyed in serving our communities.”

    Steven A. Tsavaris, Chairman of the Ponce De Leon Foundation added, “Partnership is key, especially when missions align. Humbled by these impactful groups and organizations.”

    ACE Programs: $25,000 for the Expansion of Services for Low-Income, Independently Housed Individuals in Western Queens Project

    Act Now Foundation, Inc.: $20,000 for the Alzheimer’s Care Project

    Andromeda Community Initiative: $30,000 for Constructive Career

    Brooklyn Youth Sports Club Inc: $30,000 for Brooklyn Youths Sports Club Program.

    Creative Art Works: $15,000 for Public Art Youth Employment Programs.

    Daniel’s Music Foundation: $20,000 for Disability Awareness.

    Education Through Music: $30,000 for Music Education Program.

    Girls Incorporated of New York City: $30,000 for the Project Accelerate.

    Hope Kids NY.: $25,000 for the Ready, Set, Go to College Program.

    Housing Partnership Development Corp: $30,000 for Homeownership Counseling & Education program.

    I Challenge Myself Inc: $10,000 for Cycling Smartly in The Bronx program.

    Jamaica Center for Arts & Learning Inc: $20,000 for JCAL Riddim Section.

    Neighborhood Self Help by Older Persons Project Inc (SHOPP): $30,000 for Senior Community Assistance.

    New Heights Youth Inc: $25,000 for College Bound Program.

    New York Women’s Chamber of Commerce: $30,000 for the ContractHer Program.

    Palisades Emergency Residence PERC: $15,000 for Technology Access Program.

    Part of the Solution (POTS): $30,000 for the ESOL Support Program.

    Princeton Center for Leadership & Learning: $30,000 for Connecting Gardening, Science & Literacy

    Project Hope Charities, Inc: $30,000 for Food Pantry Project.

    Regional Aid for Interim Needs Inc RAIN: $30,000 for Cucina Dolores Mobile Food Kitchen Project.

    Spanish Speaking Elderly Council RAICES: $30,000 for Mindful Journey Program.

    The HOPE Program Inc: $30,000 for Digital Literacy for Low-Income New Yorkers Program.

    Union City Music Project, Inc: $15,000 for the 2025 After School Orchestral Music Education Program.

    The Young People’s Chorus of New York City: $30,000 for YPC South Bronx Community Chorus Program.

    About the Ponce De Leon Foundation: The Ponce De Leon Foundation is a private 501(c)3 charitable corporation launched in 2017 with a generous gift of stock and cash from Ponce Bank. As the bank has grown, so has the foundation, and when Ponce Bank became a fully public entity in January of 2022 additional funds were donated. Ponce De Leon Foundation’s mission remains, to improve the quality of life in the communities in which Ponce Bank maintains full-service branches. With these gifts, Ponce Bank made clear its commitment to continue its tradition of supporting the communities it serves. For further information on the Ponce De Leon Foundation, you can send an email to Grants@Poncedeleonfoundation.org.

    About Ponce Bank: Ponce Bank is a subsidiary of Ponce Financial Group, Inc., a NASDAQ company trading under the symbol PDLB. Ponce Bank is a federally chartered stock savings association headquartered in the Bronx, New York. The Bank’s business is conducted through the administrative office, 13 branch banking offices and 5 mortgage loan centers. The banking offices are located in the Bronx (4 branches), Manhattan (2 branches), Queens (3 branches), Brooklyn (3 branches), and Union City, New Jersey (1 branch). Mortgage centers are located in Queens, (Flushing, Jamaica and Astoria) Brooklyn (Marine Park), and Bergenfield, New Jersey. The primary market area currently consists of the New York City metropolitan area. www.poncebank.com

    The MIL Network

  • MIL-OSI USA: Senator Marshall Pens Op-Ed in The Hill: RFK Jr. is the Health Revolution America Needs

    US Senate News:

    Source: United States Senator for Kansas Roger Marshall

    Washington, D.C. – U.S. Senator Roger Marshall, M.D. penned an op-ed in The Hill highlighting how President Donald Trump’s Secretary of Health and Human Services (HHS) nominee, Robert F. Kennedy Jr., is the right man to lead the health revolution that America needs to become healthy again.

    You may click HERE or on the image above to read Senator Marshall’s full op-ed. 
    Highlights from Senator Marshall’s op-ed include: 
    “For decades, American health outcomes have declined as we continue to throw money at the problem. It’s safe to say that what we are doing is not working. Our healthcare system has devolved into “sick care” — treating the disease as opposed to preventing it.”
    “I don’t agree with Kennedy on everything, but no one agrees with their colleagues 100 percent of the time. Even in my medical practice, doctors debated treatment decisions. That’s how science works — through questioning, reviewing and challenging available scientific studies and utilizing some common sense that comes with years of experience from medical practice.”
    “Kennedy and I agree that we should always scrutinize medical interventions to ensure they are necessary, safe and effective. This means holding the National Institutes of Health and the Centers for Disease Control and Prevention accountable for studying the risks, benefits, efficacy and side effects of vaccines — just as we do for all other drugs. Parents and doctors should have clear, unbiased data to make informed decisions together.”
    “Just as Trump was elected because Americans wanted a disruptor, I believe Kennedy is the disruptor our healthcare system needs. He will turn NIH, CDC, Medicare and Medicaid away from their disease-treatment mindset and toward prevention. This is not complicated. It’s common sense.”

    MIL OSI USA News

  • MIL-OSI USA: VIDEO: On Senate Floor, Rosen Announces Opposition to Confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services 

    US Senate News:

    Source: United States Senator Jacky Rosen (D-NV)

    Watch Senator Rosen’s Full Remarks HERE.
    WASHINGTON, DC – Today, U.S. Senator Jacky Rosen (D-NV) took to the Senate floor to oppose the confirmation of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. In her remarks, Senator Rosen highlighted Mr. Kennedy’s lack of qualifications and history of spreading dangerous public health conspiracies.
    Below are excerpts of Senator Rosen’s floor remarks:
    Today, we’re here to discuss President Trump’s nominee to lead the Department of Health and Human Services, Robert F. Kennedy Jr. 
    If confirmed, Mr. Kennedy would be in charge of a department with power to, well, regulate the food we eat, the medicines we take, and the vaccines we depend upon.
    He would oversee agencies that provide health care to almost 170 million Americans – including hundreds of thousands of Nevadans who are on Medicare, Medicaid, and the Children’s Health Insurance Program.
    I’m here today to oppose Robert F. Kennedy Jr. as our next Secretary of Health and Human Services. 
    Confirming him would have disastrous consequences for our public health, for seniors who rely on Medicare, for our families who get their health care through Medicaid.
    Well, let’s start out with his lack – his lack – of qualifications.
    Well, Mr. Kennedy – he’s never worked in health care or federal government. He’s probably best known for his skepticism of vaccines and spreading dangerous conspiracies and outright lies. 
    Mr. Kennedy’s history of promoting anti-vaccine misinformation – it’s well-documented and deeply troubling. 
    Vaccines have saved millions of lives throughout history, and they remain one of the most effective tools we have to protect public health. 
    Yet, Mr. Kennedy has spent years promoting debunked claims linking vaccines to autism, cancer, allergies, and autoimmune diseases. 
    He’s spread lies about vaccine safety, making people fearful and increasing rates of unvaccinated people, which put all of us – all of us – at risk.
    […]
    But his problematic views are just the start. During his confirmation hearing, Mr. Kennedy was also asked about his understanding of Medicare and Medicaid. Just asked if he knew about it.
    Well, he struggled – struggled I mind you – to remember which program covered older and disabled Americans, struggled to remember which program provided for low-income people. 
    This is Medicare and Medicaid, not something that’s so brand new that even Robert F. Kennedy Jr. shouldn’t know what it is. Because Medicare and Medicaid are not mere government programs. 
    They are a lifeline for millions of Americans, including our seniors, our parents, our grandparents, people with disabilities, families in need – including half of all children – and around forty percent of all babies born in this country.
    Why would we trust someone with the future of Medicare and Medicaid when he doesn’t even understand the basics of the system he would oversee? 
    […]
    You know, Mr. President, the role of Secretary of Health and Human Services – it is one of profound responsibility. 
    And Robert F. Kennedy Jr. has undermined the very foundations of our public health system.
    Mr. Kennedy’s vision for the future of our health care system, well, he wants to undermine Medicare and Medicaid, he wants to slash cancer research funding, he wants to push dangerous public health conspiracies. These are visions and these are things I cannot support. No one should support.
    We all want a healthier future for America — one that both prevents diseases and where we can think about curing diseases, where we can do preventative medicine, curative medicine, where we can have that hope for folks whose mother gets lung cancer in the future that she might live, or leukemia in the future, that their brother might live. 
    Mine didn’t, but I hope that they didn’t die in vain because research goes on and will help others. And I want us to be able to cure diseases for the ones that we love.
    And so that is why I cannot in good conscience support Mr. Kennedy’s nomination, and I urge my colleagues to do the same.
    The stakes couldn’t be higher. Our very lives — the lives of our loved ones — they may just depend on it.

    MIL OSI USA News

  • MIL-OSI New Zealand: Govt Cuts – Axing 63 roles at Callaghan Innovation will drive essential skills out of the country and undermine Government growth agenda – PSA

    Source: PSA

    New redundances at Callaghan Innovation will undermine the country’s capacity to commercialise innovations of New Zealand businesses, which the Government claims it is so focussed on, says the union for Callaghan Innovation workers, the Public Service Association.
    Last night, Callaghan Innovation told 63 workers their roles were being made redundant, including 16 commercialisation roles, 14 scientists and engineers, 6 Māori Innovation roles, and others working in data, digital, product design, risk and audit, marketing, government engagement and technical support.
    “The Government is dismissing the very workers who could help grow the economy,” said PSA Acting National Secretary Fleur Fitzsimons. “People working in those commercialisation roles have the skills to turn ideas into internationally marketable products and services quickly and successfully.”
    Last month, Science Minister Shane Reti told Callaghan Innovation’s Board Chair that Callaghan would lose most of its funding well before its formal disestablishment, and before any new science organisations have been set up through the science system reforms recently announced. That will see around 75 science staff out of work and forced to find work overseas.
    “The Minister is driving workers with essential knowledge out of the country. By defunding Callaghan Innovation before it’s disestablished, the Minister is forcing staff into redundancy with nowhere in New Zealand for them to go to.”
    Cabinet papers released alongside the science reform announcements stated that the Minister would conduct a review of capability within Callaghan Innovation that could be retained and transferred elsewhere. However, this review resulted in minimal change.
    “Callaghan Innovation staff were never given an opportunity to have input on this review,” said Fitzsimons. “The Minister has made decisions without even talking to the people who are losing their livelihoods over this.
    “The Minister must treat Callaghan Innovation staff with dignity and respect and find ways to keep these highly skilled staff in New Zealand. Otherwise, we’ll lose more people offshore while New Zealand becomes a less attractive place to be a scientist.
    “How will that help the Government’s economic growth agenda?”
    Previous statement on cuts at Callaghan Innovation

    MIL OSI New Zealand News

  • MIL-OSI USA: $150M for Climate Resiliency on SUNY & CUNY Campuses

    Source: US State of New York

    Governor Kathy Hochul today announced $150 million in climate resiliency grants  to make New York State’s public college campuses greener, more resilient to severe weather and more energy efficient. Supported by funding from the $4.2 billion Clean Water, Clean Air and Green Jobs Environmental Bond Act of 2022, the State University of New York (SUNY) is receiving $100 million for clean energy projects, including the installation of a thermal energy network at SUNY Buffalo, and the City University of New York (CUNY) is receiving $50 million for solar, energy storage, and heat pump projects on three campuses as part of a comprehensive plan to reduce CUNY’s carbon footprint.

    “New York’s higher education institutions play a significant role in leading by example to help advance a cleaner, greener future,” Governor Hochul said. “The $150 million in new investments from the Environmental Bond Act will allow SUNY and CUNY to take a significant step forward in electrifying campuses and integrating cleaner energy solutions to reduce pollution and help New York’s colleges become more energy efficient.”

    SUNY projects funded by the Environmental Bond Act include:

    Binghamton University: Binghamton University will install thermal energy networks and building heat pump technology on its campus. The funding will help implement construction of new high-efficiency networked water source heat pump systems in select buildings currently operating on approximately 20-year-old, lower-efficiency chillers. The new systems will effectively lower energy use by 45 percent, operating costs by $300,000, greenhouse gases by 1,100 metric tons (based on current grid emission factors), and other pollutants for the benefit of the campus and the larger community.

    University at Buffalo: UB will construct the first of many energy hubs, all of which are needed to phase out fossil fuel-based systems and replace aging, lower efficiency systems with on-site electrical systems that lower greenhouse gas and other pollutants and improve operating efficiencies. This first high-efficiency energy hub will service a network of up to five buildings on UB’s South Campus.

    SUNY Oswego: The campus will construct a geoexchange field system for a geothermal network to improve operating efficiencies, lower operating costs, and reduce greenhouse gas and other pollutants for the benefit of the campus and larger community. The project will result in an extensive underground utility infrastructure and central plant and building-level equipment conversions, which are required to continue converting the campus plant to sustainable measures.

    Stony Brook University: The Environmental Bond Act investment will provide design and construction for multiple ground and rooftop solar voltaic (PV) arrays to improve community air quality and public health and decarbonize the Long Island electric grid. The resulting on-site renewable power generation will provide operational efficiencies, energy use reduction, greenhouse gas and pollutant reductions, as well as to provide additional capacity for any potential future campus growth.

    CUNY projects funded by the Environmental Bond Act include:

    City College of New York: Parking lot solar canopies on the south campus will be paired with battery storage, which will support flexible demand management and electric vehicle (EV) chargers will be added to help electrify campus transportation. Rooftop solar will also be deployed. Heat pumps will be installed to electrify heating and cooling for the library and other spaces in the North Academic Center, and also in the science building to heat building domestic hot water and pool water. Heat Pumps are three to four times more efficient than a boiler as they move existing heat, rather than creating heat through combustion.

    Brooklyn College: Geothermal energy will be tapped as bore holes are drilled to provide ground source renewable heating and cooling for the adjacent West End Building, which houses student clubs, the film department, a testing center, and computer labs, and is a vital hub of student activity. Rooftop solar and EV charging stations will be installed at James Hall and West Quad, promoting EV adoption while supporting the college’s fleet electrification goals.

    Hunter College: This project initiates the hydronic conversion transformation of North Hall energy systems away from inefficient steam and standalone window air conditioning. Energy efficient hot and chilled water from the central plant will replace an antiquated steam system. This step toward electrification will reduce baseload energy use and cut use of fossil fuels, ensuring a better-controlled, state-of-the-art, sustainable learning environment for students.

    SUNY Chancellor John B. King Jr. said, “With thanks to Governor Hochul, SUNY’s campuses are leading the way in advancing sustainability and addressing climate change. This Bond Act funding for four SUNY projects will help achieve New York State’s ambitious decarbonization goals and build a more sustainable future.”

    CUNY Chancellor Félix V. Matos Rodríguez said, “By helping CUNY reduce the carbon footprint of our campuses, curb our consumption of fossil fuels and harness our capacity to aid sustainable energy production, Governor Hochul is enabling the University to promote prudent environmental stewardship. The Environmental Bond Act investments announced today will help CUNY play a key role in the development of a resilient, responsible, and resourceful New York.”

    New York State Department of Environmental Conservation Interim Commissioner Sean Mahar said, “Governor Hochul’s commitment in the State of the State to advance a greener future through decarbonization is bolstered with this new $150 million Clean Water, Clean Air and Green Jobs Environmental Bond Act investment for innovative clean energy projects at SUNY and CUNY campuses across the state. Through the State’s Environmental Bond Act investments, New York is supporting advanced thermal energy networks, EV charging infrastructure, and other technologies that reduce pollution, lower operating costs, and create far-reaching benefits for schools and their surrounding communities.”

    New York League of Conservation Voters President Julie Tighe said, “As the state transitions to a clean energy economy, it is critical that the government not just pass laws, but that they also lead by example. That is exactly what Governor Hochul is doing by allocating Bond Act funds to decarbonize SUNY and CUNY campuses, including by building out thermal energy networks and investing in solar and EV charging infrastructure at some of the most polluting buildings the state owns. We applaud the Governor for reducing New York’s carbon footprint while also helping seed one of the most promising clean energy solutions we have for our large buildings and campuses.”

    Building Decarbonization Coalition New York Director Lisa Dix said, “We applaud the Governor for this critical step forward in implementing the Decarbonization Leadership Program and the SUNY and CUNY campus decarbonization action plans to advance Thermal Energy Networks across our state. This funding and continued leadership is key to getting fifteen Thermal Energy Networks, shovel-ready projects by 2026. Thermal Energy Networks will advance new economic development, modernize our universities, create union jobs, help avoid costly grid upgrades, slash pollution in our communities and help achieve New York’s climate goals – all while building a thriving clean energy economy.”

    New York State AFL-CIO President Mario Cilento said, “Thanks to Governor Hochul’s leadership, the potential of the Environmental Bond Act is now becoming a reality. These projects will be built union with robust labor standards, including prevailing rate, labor peace, and Buy American. As I said in 2022, when the delegates to the New York State AFL-CIO convention voted overwhelmingly to support the Environmental Bond Act ballot referendum, working together, we will decarbonize while establishing a solid foundation for union careers.”

    New York State Building Trades President Gary LaBarbera said, “As New York looks to progress towards its climate goals, we must continue to fund clean energy initiatives that not only modernize our key institutions but also create thousands of good-paying careers for working class people. The investments from the Environmental Bond Act will help our SUNY and CUNY campuses operate in a greener and more environmentally friendly manner, generate more accessible pathways to the middle class for hardworking New Yorkers, and contribute to improving the experiences of everyone who attends and works at these colleges. We applaud Governor Hochul for supporting this investment and look forward to playing a role in pushing these climate adaptions forward.”

    New York State continues to advance resiliency initiatives and investments that are helping to protect communities. Today’s announcement complements Governor Hochul’s Executive Budget proposal to invest more than $1 billion to help fund a more sustainable and affordable future. This ambitious proposal is the single-largest climate investment in state history, generating thousands of jobs, slashing energy bills for households, and cutting harmful pollution.

    The funding to SUNY and CUNY demonstrates the ways New York State’s continued commitment can be achieved, by deploying renewable energy, advancing clean transportation and building decarbonization, and exploring emerging technologies that can support decarbonization goals and economic development. The Executive Budget also includes $108 million for climate resiliency initiatives that support coastal resiliency and additional funding for Green Resiliency Grants and continues a record $400 million for Environmental Protection Fund programs that include measures to adapt and mitigate climate impacts. Progress also continues in administering the $4.2 billion Clean Water, Clean Air and Green Jobs Environmental Bond Act, which has allocated approximately $1.25 billion, or 25 percent, of Bond Act funds to date.

    New York State’s Climate Agenda

    New York State’s climate agenda calls for an affordable and just transition to a clean energy economy that creates family-sustaining jobs, promotes economic growth through green investments, and directs a minimum of 35 percent of the benefits to disadvantaged communities. New York is advancing a suite of efforts to achieve an emissions-free economy by 2050, including in the energy, buildings, transportation, and waste sectors.

    MIL OSI USA News

  • MIL-OSI New Zealand: Universities – Deep dive on deep-water reefs finds new marine species – Vic

    Source: Te Herenga Waka—Victoria University of Wellington

    Marine researchers from Te Herenga Waka—Victoria University of Wellington have discovered a species of sea squirt that is thought to be new to science.

    The sea squirt was found off Rakiura Stewart Island while the researchers were exploring marine communities that live on the area’s deep-water reefs.

    “We were off Port Pegasus at the southern end of Rakiura and we could see all these really unusual ‘egg’ shapes on the seafloor. Closer inspection revealed they were large, 30 cm tall sea squirts that we haven’t found in any other part of Aotearoa,” said Professor James Bell, a marine biologist at the university.

    Marine ecologist Mike Page, an emeritus scientist from the National Institute of Water and Atmospheric Research, confirmed the sea squirt is likely to be a new species that is yet to be named.

    Sea squirts, also known as ascidians, play a key role in maintaining water quality. They are filter feeders—creatures that feed on nutrients in the water column.

    “Unusually, sea squirts dominated the marine communities on the deep-water reefs that we explored off Stewart Island. We typically find sponges are the dominant player on deep-water reefs in other parts of the country,” said Professor Bell.

    The new species of sea squirt was found at a depth of 115 metres.

    “The water off Stewart Island was really clear down at this depth. This probably reflects the fact there are no major rivers draining into the sea and there are still large areas of native forest on the island.”

    Video footage of the reefs shows many different species of sea squirt, varying in colour from bright white to pinks, blues, and yellows.

    The footage was taken using a remotely operated vehicle (ROV) that can film in waters of more than 100 m deep.

    “Finding this sea squirt is a reminder that we still have so much to learn about the rich diversity of life in the ocean. It’s also a reminder of the need to ensure we protect our marine environment and the unique species it supports,” said Professor Bell.

    The ROV used by the researchers to collect video footage was purchased with funding from the George Mason Charitable Trust.

    MIL OSI New Zealand News

  • MIL-OSI: MKS Instruments Reports Fourth Quarter and Full-Year 2024 Financial Results

    Source: GlobeNewswire (MIL-OSI)

    • Quarterly revenue of $935 million, above the midpoint of guidance
    • Quarterly GAAP net income of $90 million and net income per diluted share of $1.33
    • Quarterly Adjusted EBITDA of $237 million and Non-GAAP net earnings per diluted share of $2.15, above the midpoint of guidance

    ANDOVER, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today reported fourth quarter and full year 2024 financial results.

    “MKS delivered revenue and adjusted EBITDA above the midpoint of our outlook, closing out 2024 on an impressive note against a mixed demand backdrop,” said John T.C. Lee, President and Chief Executive Officer. “Our broad and deep technology portfolio serving an array of semiconductor, electronics and industrial applications enables us to address key demand opportunities as broader end market recovery begins to develop.”

    Mr. Lee added, “We enter 2025 in a strong position, highlighted by increasing customer engagement with our World Class Optics solutions, as well as solid trends in our chemistry business as we demonstrate the pivotal role we play in advanced electronics.”

    “Our revenue and profitability remained robust in the fourth quarter as our team executed well,” said Ram Mayampurath, Executive Vice President, Chief Financial Officer and Treasurer.

    Mr. Mayampurath added, “We delivered continued healthy gross margin, earnings per share growth and increased operating cash flow in 2024. This underscores the value customers see in our technology portfolio as well as our strong focus on both cost management and cash generation. We also continue to make good progress proactively managing our leverage, completing another repricing of our term loan B and making a voluntary principal prepayment of $100 million in January.”

    First Quarter 2025 Guidance

    For the first quarter of 2025, the Company expects revenue of $910 million, plus or minus $40 million, GAAP net income of $43 million, plus or minus $19 million, Adjusted EBITDA of $217 million, plus or minus $23 million, GAAP net income per diluted share of $0.63, plus or minus $0.28, and Non-GAAP net earnings per diluted share of $1.40, plus or minus $0.27. The guidance for the first quarter is based on the current business environment, including the immaterial impact of the recently announced U.S. import tariffs up through but not including the date of this release. This guidance does not reflect the imposition of any other import tariffs by the United States or potential retaliatory actions taken by other countries. The Company will continue to monitor and adapt to changes in the business environment as needed.

    Conference Call Details

    A conference call with management will be held on Thursday, February 13, 2025 at 8:30 a.m. (Eastern Time). To participate in the call by phone, participants should visit the Investor Relations section of MKS’ website at investor.mks.com and click on Events & Presentations, where you will be able to register online and receive dial-in details. We encourage participants to register and dial in to the conference call at least 15 minutes before the start of the call to ensure a timely connection. A live and archived webcast and related presentation materials will be available on the Investor Relations section of the MKS website.

    About MKS Instruments

    MKS Instruments enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed, feature enhancement, and optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com.

    Use of Non-GAAP Financial Results

    This press release includes financial measures that are not in accordance with U.S. generally accepted accounting principles (“Non-GAAP financial measures”). These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS’ reported results under U.S. generally accepted accounting principles (“GAAP”), and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results. For further information regarding these Non-GAAP financial measures, please refer to the tables presenting reconciliations of our Non-GAAP results to our GAAP results and the “Notes on Our Non-GAAP Financial Information” at the end of this press release.

    Selected GAAP and Non-GAAP Financial Measures
    (In millions, except per share data)

      Quarter   Full Year
      Q4 2024   Q3 2024   Q4 2023     2024       2023  
    Net Revenues                  
    Semiconductor $ 400     $ 378     $ 362     $ 1,498     $ 1,479  
    Electronics & Packaging   254       231       226     $ 922     $ 916  
    Specialty Industrial   281       287       305     $ 1,166     $ 1,227  
    Total net revenues $ 935     $ 896     $ 893     $ 3,586     $ 3,622  
    GAAP Financial Measures                  
    Gross margin   47.2 %     48.2 %     46.0 %     47.6 %     45.3 %
    Operating margin   14.5 %     14.3 %     2.7 %     13.9 %     (42.9 %)
    Net income (loss) $ 90     $ 62     $ (68 )   $ 190     $ (1,841 )
    Diluted income (loss) per share $ 1.33     $ 0.92       (1.02 )   $ 2.81     $ (27.54 )
    Non-GAAP Financial Measures                  
    Gross margin   47.2 %     48.2 %     46.0 %     47.6 %     45.7 %
    Operating margin   21.3 %     21.8 %     20.3 %     21.3 %     19.5 %
    Net earnings $ 146     $ 116     $ 78     $ 444     $ 297  
    Diluted earnings per share $ 2.15     $ 1.72     $ 1.17     $ 6.58     $ 4.43  
                                           

    Additional Financial Information

    At December 31, 2024, the Company had $714 million in cash and cash equivalents, $3.2 billion of secured term loan principal outstanding, $1.4 billion of convertible senior notes outstanding and up to $675 million of additional borrowing capacity under a revolving credit facility, subject to certain leverage ratio requirements. During the fourth quarter of 2024, the Company paid a cash dividend of $15 million or $0.22 per diluted share and made a voluntary principal prepayment of €200 million, which equated to $216 million, on its EUR term loan B.

    In January 2025, the Company completed the repricing of its USD term loan B and EUR term loan B and made a voluntary principal prepayment of $100 million on its USD term loan B.

    SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

    This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of MKS Instruments, Inc. (“MKS,” the “Company,” “our,” or “we”). These statements are only predictions based on current assumptions and expectations. Any statements that are not statements of historical fact (including statements containing the words “will,” “projects,” “intends,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” “forecasts,” “continues” and similar expressions) should be considered to be forward-looking statements. Actual events or results may differ materially from those in the forward-looking statements set forth herein. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements that we make are the level and terms of our substantial indebtedness and our ability to service such debt; our entry into the chemicals technology business through our acquisition of Atotech Limited (“Atotech”) in August 2022 (the “Atotech Acquisition”), which has exposed us to significant additional liabilities; the risk that we are unable to realize the anticipated benefits of the Atotech Acquisition; legal, reputational, financial and contractual risks resulting from the ransomware incident we identified in February 2023, and other risks related to cybersecurity, data privacy and intellectual property; competition from larger, more advanced or more established companies in our markets; the ability to successfully grow our business, including through growth of the Atotech business and growth of the Electro Scientific Industries, Inc. business, which we acquired in February 2019, and financial risks associated with those and potential future acquisitions, including goodwill and intangible asset impairments; manufacturing and sourcing risks, including those associated with limited and sole source suppliers and the impact and duration of supply chain disruptions, component shortages, and price increases; changes in global demand; the impact of a pandemic or other widespread health crisis; risks associated with doing business internationally, including geopolitical conflicts, such as the conflict in the Middle East, trade compliance, trade protection measures, such as import tariffs by the United States or retaliatory actions taken by other countries, regulatory restrictions on our products, components or markets, particularly the semiconductor market, and unfavorable currency exchange and tax rate fluctuations, which risks become more significant as we grow our business internationally and in China specifically; conditions affecting the markets in which we operate, including fluctuations in capital spending in the semiconductor, electronics manufacturing and automotive industries, and fluctuations in sales to our major customers; disruptions or delays from third-party service providers upon which our operations may rely; the ability to anticipate and meet customer demand; the challenges, risks and costs involved with integrating or transitioning global operations of the companies we have acquired; risks associated with the attraction and retention of key personnel; potential fluctuations in quarterly results; dependence on new product development; rapid technological and market change; acquisition strategy; volatility of stock price; risks associated with chemical manufacturing and environmental regulation compliance; risks related to defective products; financial and legal risk management; and the other important factors described under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023 and any subsequent Quarterly Reports on Form 10-Q, each as filed with the U.S. Securities and Exchange Commission. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise, even if subsequent events cause our views to change, after the date of this press release. Amounts reported in this press release are preliminary and subject to finalization prior to the filing of our Annual Report on Form 10-K for the year ended December 31, 2024.

    Company Contact:
    Paretosh Misra
    Vice President, Investor Relations
    Telephone: (978) 284-4705
    Email: paretosh.misra@mks.com 

    MKS Instruments, Inc.
    Unaudited Consolidated Statements of Operations
    (In millions, except per share data)
                       
      Three Months Ended   Twelve Months Ended
      December 31,   September 30,   December 31,   December 31,   December 31,
        2024       2024       2023       2024       2023  
    Net revenues:                  
    Products $ 824     $ 776     $ 785     $ 3,124     $ 3,200  
    Services   111       120       108       462       422  
    Total net revenues   935       896       893       3,586       3,622  
    Cost of revenues:                  
    Products   443       410       423       1,662       1,748  
    Services   51       54       59       216       232  
    Total cost of revenues (exclusive of amortization shown separately below)   494       464       482       1,878       1,980  
    Gross profit   441       432       411       1,708       1,642  
    Research and development   65       70       70       271       288  
    Selling, general and administrative   176       167       160       674       675  
    Acquisition and integration costs   3       3       3       9       16  
    Restructuring and other   1       1       7       6       20  
    Fees and expenses related to the repricing of Term Loan Facility         2       2       5       2  
    Amortization of intangible assets   61       61       70       245       295  
    Goodwill and intangible asset impairment               75             1,902  
    Gain on sale of long-lived assets                           (2 )
    Income (loss) from operations   135       128       24       498       (1,554 )
    Interest income   (5 )     (6 )     (7 )     (21 )     (17 )
    Interest expense   54       64       90       284       356  
    Loss on extinguishment of debt   4       5       8       57       8  
    Other expense (income), net   3       5       12       (2 )     27  
    Income (loss) before income taxes   79       60       (79 )     180       (1,928 )
    (Benefit) provision for income taxes   (11 )     (2 )     (11 )     (10 )     (87 )
    Net income (loss) $ 90     $ 62     $ (68 )   $ 190     $ (1,841 )
    Net income (loss) per share:                  
    Basic $ 1.34     $ 0.92     $ (1.02 )   $ 2.82     $ (27.54 )
    Diluted $ 1.33     $ 0.92     $ (1.02 )   $ 2.81     $ (27.54 )
    Cash dividends per common share $ 0.22     $ 0.22     $ 0.22     $ 0.88     $ 0.88  
    Weighted average shares outstanding:                  
    Basic   67.4       67.4       66.9       67.3       66.8  
    Diluted   67.7       67.6       66.9       67.6       66.8  
    MKS Instruments, Inc.
    Unaudited Consolidated Balance Sheets
    (In millions)
           
           
      December 31,   December 31,
        2024       2023  
    ASSETS      
    Cash and cash equivalents $ 714     $ 875  
    Trade accounts receivable, net   615       603  
    Inventories   893       991  
    Other current assets   252       227  
    Total current assets   2,474       2,696  
    Property, plant and equipment, net   771       784  
    Right-of-use assets   238       225  
    Goodwill   2,479       2,554  
    Intangible assets, net   2,272       2,619  
    Other assets   356       240  
    Total assets $ 8,590     $ 9,118  
    LIABILITIES AND STOCKHOLDERS’ EQUITY      
    Short-term debt $ 50     $ 93  
    Accounts payable   341       327  
    Other current liabilities   384       428  
    Total current liabilities   775       848  
    Long-term debt, net   4,488       4,696  
    Non-current deferred taxes   504       640  
    Non-current accrued compensation   141       151  
    Non-current lease liabilities   211       205  
    Other non-current liabilities   149       106  
    Total liabilities   6,268       6,646  
    Stockholders’ equity:      
    Common stock          
    Additional paid-in capital   2,067       2,195  
    Retained earnings   503       373  
    Accumulated other comprehensive loss   (248 )     (96 )
    Total stockholders’ equity   2,322       2,472  
    Total liabilities and stockholders’ equity $ 8,590     $ 9,118  
           
    MKS Instruments, Inc.
    Unaudited Consolidated Statements of Cash Flows
    (In millions)
                       
      Three Months Ended   Twelve Months Ended
      December 31,   September 30,   December 31,   December 31,   December 31,
        2024       2024       2023       2024       2023  
    Cash flows from operating activities:                  
    Net income (loss) $ 90     $ 62     $ (68 )   $ 190     $ (1,841 )
    Adjustments to reconcile net income (loss) to net cash provided by operating activities:                  
    Depreciation and amortization   87       87       95       348       397  
    Goodwill and intangible asset impairments               75             1,902  
    Unrealized loss (gain) on derivatives not designated as hedging instruments   11       2       10       13       32  
    Amortization of debt issuance costs and original issue discount   7       7       10       30       33  
    Loss on extinguishment of debt   4       5       8       57       8  
    Gain on sale of long-lived assets                           (2 )
    Stock-based compensation   11       11       11       48       54  
    Provision for excess and obsolete inventory   15       16       10       56       64  
    Deferred income taxes   (58 )     (72 )     (61 )     (226 )     (234 )
    Other   2       2             8       5  
    Changes in operating assets and liabilities, net of acquired assets and liabilities   7       43       90       4       (99 )
    Net cash provided by operating activities   176       163       180       528       319  
    Cash flows from investing activities:                  
    Proceeds from sale of long-lived assets         1             1       3  
    Purchases of property, plant and equipment   (51 )     (22 )     (34 )     (118 )     (87 )
    Net cash used in investing activities   (51 )     (21 )     (34 )     (117 )     (84 )
    Cash flows from financing activities:                  
    Proceeds from borrowings               214       2,161       216  
    Payments of borrowings   (229 )     (123 )     (336 )     (2,427 )     (403 )
    Purchase of capped calls related to Convertible Notes                     (167 )      
    Payments of deferred financing fees               (9 )     (33 )     (9 )
    Dividend payments   (15 )     (15 )     (15 )     (59 )     (59 )
    Net proceeds (payments) related to employee stock awards   3       (1 )     4       (9 )     (1 )
    Other financing activities   (5 )     (5 )     (1 )     (15 )     (3 )
    Net cash used in financing activities   (246 )     (144 )     (143 )     (549 )     (259 )
    Effect of exchange rate changes on cash and cash equivalents   (26 )     13       13       (23 )     (10 )
    (Decrease) increase in cash and cash equivalents   (147 )     11       16       (161 )     (34 )
    Cash and cash equivalents at beginning of period   861       850       859       875       909  
    Cash and cash equivalents at end of period $ 714     $ 861       875     $ 714     $ 875  
                       
    The following supplemental Non-GAAP earnings information is presented to aid in understanding MKS’ operating results:            
                       
    MKS Instruments, Inc.
    Schedule Reconciling Selected Non-GAAP Financial Measures
    (In millions, except per share data)
                       
                       
      Three Months Ended   Twelve Months Ended
      December 31,   September 30,   December 31,   December 31,   December 31,
        2024       2024       2023       2024       2023  
    Net income (loss) $ 90     $ 62     $ (68 )   $ 190     $ (1,841 )
    Acquisition and integration costs (Note 1)   3       3       3       9       16  
    Restructuring and other (Note 2)   1       1       7       6       20  
    Amortization of intangible assets   61       61       70       245       295  
    Loss on debt extinguishment (Note 3)   4       5       8       57       8  
    Amortization of debt issuance costs (Note 4)   5       5       7       21       24  
    Fees and expenses related to repricing of Term Loan Facility (Note 5)         2       2       5       2  
    Goodwill and intangible asset impairment (Note 6)               75             1,902  
    Gain on sale of long-lived assets (Note 7)                           (2 )
    Ransomware incident (Note 8)               1             15  
    Excess and obsolete charge from discontinued product line (Note 9)                           13  
    Tax effect of Non-GAAP adjustments (Note 10)   (18 )     (23 )     (26 )     (89 )     (156 )
    Non-GAAP net earnings $ 146     $ 116     $ 78     $ 444     $ 297  
    Non-GAAP net earnings per diluted share $ 2.15     $ 1.72     $ 1.17     $ 6.58     $ 4.43  
    Weighted average diluted shares outstanding   67.7       67.6       67.1       67.6       67.0  
                       
    Net cash provided by operating activities $ 176     $ 163     $ 180     $ 528     $ 319  
    Purchases of property, plant and equipment   (51 )     (22 )     (34 )     (118 )     (87 )
    Free cash flow $ 125     $ 141     $ 146     $ 410     $ 232  
                       
    MKS Instruments, Inc.
    Schedule Reconciling Selected Non-GAAP Financial Measures
    (In millions)
                       
      Three Months Ended   Twelve Months Ended
      December 31,   September 30,   December 31,   December 31,   December 31,
        2024       2024       2023       2024       2023  
    Gross profit $ 441     $ 432     $ 411     $ 1,708     $ 1,642  
    Gross margin   47.2 %     48.2 %     46.0 %     47.6 %     45.3 %
    Excess and obsolete charge from discontinued product line (Note 9)                           13  
    Non-GAAP gross profit $ 441     $ 432     $ 411     $ 1,708     $ 1,655  
    Non-GAAP gross margin   47.2 %     48.2 %     46.0 %     47.6 %     45.7 %
    Operating expenses $ 306     $ 304     $ 387     $ 1,210     $ 3,196  
    Acquisition and integration costs (Note 1)   3       3       3       9       16  
    Restructuring and other (Note 2)   1       1       7       6       20  
    Amortization of intangible assets   61       61       70       245       295  
    Fees and expenses related to repricing of Term Loan Facility (Note 5)         2       2       5       2  
    Goodwill and intangible asset impairment (Note 6)               75             1,902  
    Gain on sale of long-lived assets (Note 7)                           (2 )
    Ransomware incident (Note 8)               1             15  
    Non-GAAP operating expenses $ 242     $ 237     $ 229     $ 945     $ 948  
    Income (loss) from operations $ 135     $ 128     $ 24     $ 498     $ (1,554 )
    Operating margin   14.5 %     14.3 %     2.7 %     13.9 %     (42.9 %)
    Acquisition and integration costs (Note 1)   3       3       3       9       16  
    Restructuring and other (Note 2)   1       1       7       6       20  
    Amortization of intangible assets   61       61       70       245       295  
    Fees and expenses related to repricing of Term Loan Facility (Note 5)         2       2       5       2  
    Goodwill and intangible asset impairment (Note 6)               75             1,902  
    Gain on sale of long-lived assets (Note 7)                           (2 )
    Ransomware incident (Note 8)               1             15  
    Excess and obsolete charge from discontinued product line (Note 9)                           13  
    Non-GAAP income from operations $ 199     $ 195     $ 182     $ 763     $ 707  
    Non-GAAP operating margin   21.3 %     21.8 %     20.3 %     21.3 %     19.5 %
    Interest expense, net $ 49     $ 58     $ 83     $ 263     $ 339  
    Amortization of debt issuance costs (Note 4)   5       5       7       21       24  
    Non-GAAP interest expense, net $ 45     $ 53     $ 76     $ 242     $ 315  
    Net income (loss) $ 90     $ 62     $ (68 )   $ 190     $ (1,841 )
    Interest expense, net   49       58       83       263       339  
    Other expense (income), net   3       5       12       (2 )     27  
    (Benefit) provision for income taxes   (11 )     (2 )     (11 )     (10 )     (87 )
    Depreciation   26       26       25       103       102  
    Amortization   61       61       70       245       295  
    Stock-based compensation   11       11       11       48       54  
    Acquisition and integration costs (Note 1)   3       3       3       9       16  
    Restructuring and other (Note 2)   1       1       7       6       20  
    Loss on debt extinguishment (Note 3)   4       5       8       57       8  
    Fees and expenses related to repricing of Term Loan Facility (Note 5)         2       2       5       2  
    Goodwill and intangible asset impairment (Note 6)               75             1,902  
    Gain on sale of long-lived assets (Note 7)                           (2 )
    Ransomware incident (Note 8)               1             15  
    Excess and obsolete charge from discontinued product line (Note 9)                           13  
    Adjusted EBITDA $ 237     $ 232     $ 218     $ 914     $ 863  
    Adjusted EBITDA margin   25.3 %     25.9 %     24.4 %     25.5 %     23.8 %
                       
    MKS Instruments, Inc.
    Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate
    (In millions)
                           
                           
      Three Months Ended December 31, 2024   Three Months Ended December 31, 2023
      Income Before   (Benefit) Provision   Effective   (Loss) Income Before   (Benefit) Provision   Effective
      Income Taxes   for Income Taxes   Tax Rate   Income Taxes   for Income Taxes   Tax Rate
                           
    GAAP $ 79   $ (11 )   (14.5 %)   $ (79 )   $ (11 )   14.2 %
    Acquisition and integration costs (Note 1)   3               3            
    Restructuring and other (Note 2)   1               7            
    Amortization of intangible assets   61               70            
    Loss on debt extinguishment (Note 3)   4               8            
    Amortization of debt issuance costs (Note 4)   5               7            
    Fees and expenses related to repricing of Term Loan Facility (Note 5)                 2            
    Goodwill and intangible asset impairment (Note 6)                 75            
    Ransomware incident (Note 8)                 1            
    Tax effect of Non-GAAP adjustments (Note 10)       18                 26      
    Non-GAAP $ 153   $ 7     4.0 %   $ 94     $ 15     15.6 %
                           
      Three Months Ended September 30, 2024
      Income Before   (Benefit) Provision    Effective
      Income Taxes   for Income Taxes   Tax Rate
    GAAP $ 60   $ (2 )   (4.0 %)
    Acquisition and integration costs (Note 1)   3          
    Restructuring and other (Note 2)   1          
    Amortization of intangible assets   61          
    Loss on debt extinguishment (Note 3)   5          
    Amortization of debt issuance costs (Note 4)   5          
    Fees and expenses related to repricing of Term Loan Facility (Note 5)   2          
    Tax effect of Non-GAAP adjustments (Note 10)       23      
    Non-GAAP $ 137   $ 21     15.1 %
               
      Twelve Months Ended December 31, 2024   Twelve Months Ended December 31, 2023
      Income Before   (Benefit) Provision   Effective   (Loss) Income Before   (Benefit) Provision    Effective
      Income Taxes   for Income Taxes   Tax Rate   Income Taxes   for Income Taxes   Tax Rate
    GAAP $ 180   $ (10 )   (5.7 %)   $ (1,928 )   $ (87 )   4.5 %
    Acquisition and integration costs (Note 1)   9               16            
    Restructuring and other (Note 2)   6               20            
    Amortization of intangible assets   245               295            
    Loss on debt extinguishment (Note 3)   57               8            
    Amortization of debt issuance costs (Note 4)   21               24            
    Fees and expenses related to repricing of Term Loan Facility (Note 5)   5               2            
    Goodwill and intangible asset impairment (Note 6)                 1,902            
    Gain on sale of long-lived assets (Note 7)                 (2 )          
    Ransomware incident (Note 8)                 15            
    Excess and obsolete charge from discontinued product line (Note 9)                 13            
    Tax effect of Non-GAAP adjustments (Note 10)       89                 156      
    Non-GAAP $ 523   $ 78     14.8 %   $ 366     $ 69     18.9 %
                           
    MKS Instruments, Inc.  
    Schedule Reconciling Selected Non-GAAP Financial Measures – Q1’25 Guidance  
    (In millions, except per share data)  
               
               
        Three Months Ending March 31, 2025  
        $ Amount   Per Share  
    GAAP net income and net income per share   $ 43     $ 0.63  
    Amortization of intangible assets     60        
    Loss on debt extinguishment     3        
    Amortization of debt issuance costs     4        
    Fees and expenses related to repricing of Term Loan Facility     2        
    Tax effect of Non-GAAP adjustments     (17 )      
    Non-GAAP net earnings and net earnings per share   $ 95     $ 1.40  
    Estimated weighted average diluted shares     67.8        
               
    GAAP operating expenses   $ 317        
    Amortization of intangible assets     (60 )      
    Fees and expenses related to repricing of Term Loan Facility     (2 )      
    Non-GAAP operating expenses   $ 255        
               
    GAAP net income     43        
    Interest expense, net     50        
    Provision for income taxes     10        
    Depreciation     26        
    Amortization of intangible assets     60        
    Stock-based compensation     23        
    Loss on debt extinguishment     3        
    Fees and expenses related to repricing of Term Loan Facility     2        
    Adjusted EBITDA   $ 217        
               

    MKS Instruments, Inc.
    Notes on Our Non-GAAP Financial Information

    Non-GAAP financial measures adjust GAAP financial measures for the items listed below. These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS’ reported GAAP results, and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results. Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.

    Note 1: Acquisition and integration costs related to the Atotech Acquisition.

    Note 2: Restructuring costs primarily related to severance costs due to global cost-saving initiatives. Other costs related to certain legal matters.

    Note 3:  During the three and twelve months ended December 31, 2024, we recorded charges to write-off deferred financing fees and original issue discount costs related to voluntary principal prepayments on our USD term loan B. During the three months ended September 30, 2024 and the twelve months ended December 31, 2024, we recorded charges to write-off deferred financing fees and original issue discount costs related to the repricing of our USD term loan B and EUR term loan B. Additionally, during the twelve months ended December 31, 2024, we recorded charges to (i) write-off deferred financing fees and original issue discount costs related to voluntary principal prepayments on our EUR term loan B and (ii) write-off deferred financing fees related to the extinguishment of our term loan A. During the three and twelve months ended December 31, 2023, we recorded a charge to write-off deferred financing fees and original issue discount costs related to the repricing of our USD term loan B and the voluntary prepayment on our USD Tranche A loan.

    Note 4: We recorded additional interest expense related to the amortization of deferred financing costs associated with our term loan facility.

    Note 5: During the twelve months ended December 31, 2024 and the three months ended September 30, 2024, we recorded fees and expenses related to the repricing of our USD term loan B and EUR term loan B. During the twelve months ended December 31, 2024, we also recorded fees and expenses related to an amendment to our term loan facility where we borrowed additional amounts under our USD term loan B and EUR term loan B and fully repaid our term loan A. During the three and twelve months ended December 31, 2023, we recorded fees and expenses related to the repricing of our USD term loan B.

    Note 6: During the twelve months ended December 31, 2023, we noted softer industry demand, particularly in the personal computer and smartphone markets and concluded there was a triggering event at our Materials Solutions Division, which represents the former Atotech business, and Equipment Solutions Business, which represents the former Electro Scientific Industries business and is a reporting unit of our Photonics Solutions Division. We performed a quantitative assessment which resulted in an impairment of $1.3 billion for our Materials Solutions Division and $0.5 billion for our Equipment Solutions Business. In addition, during the three months ended December 31, 2023, as part of our annual goodwill and intangible asset impairment analysis, we recorded additional impairment charges of $62 million for our Materials Solutions Division and $13 million for our Equipment Solutions Business.

    Note 7: We recorded a gain on the sale of a minority interest investment in a private company.

    Note 8: We recorded costs, net of recoveries, associated with the ransomware incident we identified on February 3, 2023. These costs were primarily comprised of various third-party consulting services, including forensic experts, restoration experts, legal counsel, and other information technology and accounting professional expenses, enhancements to our cybersecurity measures, and costs to restore our systems and access our data.

    Note 9: We recorded an excess and obsolescence inventory charge related to a product line that was discontinued.

    Note 10: Non-GAAP adjustments are tax effected at applicable statutory rates resulting in a difference between the GAAP and Non-GAAP tax rates.

    The MIL Network

  • MIL-OSI Submissions: U.S. Foreign Aid Freeze Disrupts Lifesaving Health Care, Services for Survivors of Sexual Violence Midst Deadly Conflict in Democratic Republic of the Congo: PHR

    Source: Physicians for Human Rights (PHR)

    February 12, 2025 – The Trump administration’s executive order to freeze U.S. foreign aid for 90 days has halted the supply of lifesaving medical care to populations facing rising conflict in eastern Democratic Republic of the Congo (DRC) including survivors of conflict-related sexual violence, said Physicians for Human Rights (PHR).

    The order was issued as the M23 militia moves deeper into eastern DRC after taking Goma, the largest city and the capital of North Kivu, in January, further destabilizing the region’s dire humanitarian crisis. More than 500,000 people in North and South Kivu have been displaced due to the escalation of violence by armed groups, while health facilities have been subjected to indiscriminate shooting and bombing. There is an acute risk of further violence as M23 advances south in DRC and the United Nations has expressed concern about the significant increase of sexual violence. A rapid assessment of health care facilities in and around Goma conducted by the WHO found 45 cases of rape and gender-based violence reported among the displaced and 21 survivors of multiple-perpetrator rape admitted to medical facilities in recent days. The actual number of cases is likely much higher in light of barriers to reporting.  

    “Health facilities in eastern DRC are struggling as they try to provide health care in unimaginable conditions,” said Payal Shah, JD, PHR director of research, legal, and advocacy. “The United States pulled funding right when besieged communities in DRC needed international support the most. Health workers are risking their lives to address the rise in injuries, deaths, displacements, and cases of sexual violence. Now, they must do so without the vital support of foreign aid from the United States, which accounted for nearly 70 percent of humanitarian funding to DRC last year.”  

    PHR partner medical facilities and humanitarian organizations in the region reported a massive influx of cases of survivors of sexual violence in 2024, including children, who require specialized support. These facilities were already overburdened by mass displacements and the outbreak of infectious diseases including mpox.  

    HEAL Africa, a center for medical, psychosocial, and legal support for survivors of sexual violence in North Kivu, has been forced to halt critical projects related to the care of adult and child survivors of sexual violence, including the treatment of fistulas, specialized psychosocial care, and protection for child survivors. In places like Bulengo, an internally displaced persons camp in North Kivu, services like child-friendly spaces for younger survivors of sexual violence are at risk of being abandoned due to forced closure, attacks on health care facilities, and staffing shortages due to the U.S. aid freeze.  

    The funding freeze has also significantly impacted access to essential health supplies and resources, including blood bank reserves and post-exposure prophylaxis (PEP) kits for HIV. These kits, which are expensive and can be difficult to procure, are a key tool in post-rape care as they typically include prophylaxis medication and a copy of a medicolegal forensic form used by providers to collect forensic evidence and support justice processes for survivors. Many facilities will run out of supplies within days if financial support does not resume. 

    “For survivors, the lack of health care is compounding the trauma of sexual violence and leading to grave risks of lifelong debilitating health conditions. Urgent and coordinated action is needed on the part of international actors and all parties to the ongoing conflict to respond to this conflict, including to prevent violence and ensure care for survivors of sexual violence,” said Shah. “The U.S. government must use its influence to ensure all parties abide by international humanitarian law and it must end the 90-day freeze on foreign funding support, which is indispensable to the development, security, and facilitation of humanitarian aid in DRC.”

    “All parties to the ongoing conflict in DRC must support safe access to resources via dedicated humanitarian corridors to enable the continued supply of essential medical supplies and services. Each day that goes by without funding for lifesaving health interventions as well as legal and psychosocial support is causing devastating, preventable harm for countless individuals in eastern DRC,” said Shah.

    Physicians for Human Rights (PHR) is a global advocacy organization that uses science and medicine to prevent mass atrocities and severe human rights violations. Learn more here: https://phr.org/about/

    MIL OSI – Submitted News

  • MIL-OSI Submissions: Japan’s Expertise in International Assistance: Leveraging Experiences Gained in Southeast Asia to Aid Ukraine -The Shared Future of Asia and Japan

    Source: Japan Connect

    Diplomacy / InternationalAsia & Pacific

    In 2022, Russia invaded Ukraine. The Russian military has continuously been launching missiles and artillery attacks on civilian facilities, causing great damage to the lives of the Ukrainian people. Japan is offering various assistance through public and private endeavors to rebuild lives, drawing on experiences gained through providing aid to countries in Southeast Asia.

    One such example is a water supply aid project. As part of the government’s gratuitous recovery assistance, Japan is sending mobile water purification systems and ready-to-assemble water supply tanks to Ukraine’s cities where water supply networks were destroyed.

    As part of this initiative, Nihon Genryo Co., Ltd., a manufacturer of water treatment systems headquartered in Kawasaki, Kanagawa Prefecture, delivered four Mobile Siphon Tanks, a mobile water purification system, to Ukraine’s capital Kyiv and the southern port city Odesa. The system, developed by Nihon Genryo, does not require filter replacements, which were necessary in previous water purification systems. The company also invited water supply technicians in Kyiv to Japan and conducted training on water purification technology.

    Nihon Genryo has been deeply involved in Southeast Asia. In 1982, it delivered fully automatic dust scrapers to the Bangkhen Water Treatment Plant in Bangkok, Thailand, to help remove impurities and provide safe, treated water. It also delivered Mobile Siphon Tanks to cities in Laos and Vietnam as part of Japan’s Official Development Assistance (ODA) and is training local staff on how to use them. In Laos, the company carried out emergency water supply operations during flood disasters in 2013 and 2020. In the Philippines, it provided drinking water to regions without access to a water supply by using river water. It also carried out emergency water supply operations at the request of the Japanese government in the wake of disasters such as Super Typhoon Haiyan in 2013 and Super Typhoon Rai in 2021. In this way, the company gained extensive experience assisting the lives and lifestyles of people in Southeast Asia, which is now being leveraged to help Ukraine, halfway across the globe in Europe.

    In addition to water supply assistance, Japan also has international experience in providing aid to people with disabilities. Since Russia’s invasion, over 300,000 Ukrainian troops and civilians have become disabled as a result of injuries. However, medical equipment is growing outdated due to a shortage of funds, and providing assistance is an urgent matter. Japan provided rehabilitation equipment and welfare vehicles to 11 facilities in Kyiv Oblast through the Japan International Cooperation Agency (JICA). In December 2024, a commemorative ceremony was held in Kyiv. Ruslan Kravchenko, the governor of Kyiv Oblast, expressed his gratitude, saying, “We thank the Japanese government and its people for their extensive support. This will allow us to greatly improve the conditions for people with disabilities.”

    Japan has also been committed to providing aid to people with disabilities in Southeast Asia. Gratuitous financial assistance was offered to Indonesia, for example, by providing mobile rehabilitation equipment in 1989 and taking part in a project to construct a vocational rehabilitation center for people with disabilities in 1995. In addition to dispatching Japanese specialists and Japan Overseas Cooperation Volunteers (JOCVs) to countries like Thailand and the Philippines, Japan also invites trainees from various countries to Japan through JICA initiatives to help raise rehabilitation standards for people with disabilities.

    Removing landmines is another urgent issue that must be addressed in Ukraine. It is believed that the Russian military may have planted mines in an area of up to 150,000 square kilometers, which amounts to over a fourth of the country’s land. The Japanese government has been engaged in mine clearance efforts in Cambodia for many years. Drawing on this experience, it is offering comprehensive support to Ukraine by providing resources developed by Japanese companies, such as mine detectors, mine removers and systems using artificial intelligence (AI) to identify areas where mines have been planted, in addition to training on how to prevent injuries and offering aid to victims.

    Japan is also working on assisting Ukrainian soldiers and civilians who survived mines but lost their limbs.

    Instalimb, Inc. is a startup company headquartered in Tokyo that utilizes digital technology to create prosthetic legs. The company uses a special scanner to capture the shape of a patient’s leg and creates a 3D-printed prosthetic based on data designed by a prosthetist using software.
    The CEO of the company, Yutaka Tokushima, said in an interview with the Japanese broadcasting network TBS Television, “One (of the merits) is that we can create prosthetics very quickly. Where it usually takes a month, we can do it in a day (at the quickest) and significantly lower the cost. Another merit is that one professional prosthetist can make many prosthetics.” 
    Prosthetic legs cost around 400,000 yen in Japan, but Tokushima says the company can reduce it to one-tenth of that amount.
    Instalimb has its roots in the Philippines. After working at a computer-related company and as a designer of industrial products, Tokushima joined the JOCV program under JICA and was posted to the Philippines in 2012. 
    Later, with support from JICA and the Philippine government, he established a laboratory equipped with a 3D printer and laser cutter for industrial development. After he learned that many people in the Philippines needed prosthetic legs as a result of diabetes, he took on the challenge of developing high-performance yet affordable prosthetics. Over the course of four years, he developed a technology that specialized in creating prosthetic legs using 3D printing. These prosthetics are now available to people in the Philippines who cannot afford conventional ones.

    As he works on creating prosthetics in Ukraine, Tokushima says, “Many people want to recover and rebuild their lives, but they can’t work because they don’t have access to prosthetic legs. So I want to give them hope, first and foremost. Our current mission is to provide prosthetics to each and every person who needs them as we aim for the ultimate goal of helping all the people of Ukraine regain their bright future.” A Japanese company, born in the Philippines, is now striving to help the wounded people of Ukraine.

    Japan is offering aid to Ukraine in a diverse range of fields including infrastructure, education, agriculture, economy, machinery and culture—and much of this expertise comes from the experience Japan gained in Southeast Asia.

    By Akio Yaita
    Journalist. Graduated from the Faculty of Letters at Keio University. After completing his doctorate at the Chinese Academy of Social Sciences, he worked as a correspondent for the Sankei Shimbun in Beijing and as Taipei bureau chief. Author or co-author of many books.

    *The stories and materials above are provided by JIJI.com or AFPBBNews. Feel free to feature these stories in your own media.

    About “Japan Connect”
    Bringing you the latest stories about Japan.
    This new service is provided by AFPBB News, which AFP launched in 2007.

    MIL OSI – Submitted News